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ABSTRACT OF THE DISSERTATION 
NOVEL ROLE OF PSEUDOMONAS AERUGINOSA LPTD OPERON 
by 
Sundar Pandey 
Florida International University, 2018 
Miami, Florida 
Professor Kalai Mathee, Major Professor 
Pseudomonas aeruginosa is an opportunistic pathogen that infects cystic fibrosis (CF) 
patients contributing to their high morbidity and mortality. P. aeruginosa undergoes a 
phenotypic conversion in the CF lung, from nonmucoid to mucoid, by constitutively 
producing a polysaccharide called alginate. These mucoid strains often revert to 
nonmucoid in vitro due to second-site suppressor mutations. We hypothesized that 
mapping these mutations would lead to the identification of novel genes involved in 
alginate production. In a previous study, a mucoid strain, PDO300 (PAOmucA22), was 
used to isolate suppressors of alginate phenotype (sap). One of the uncharacterized 
nonmucoid revertants, sap27, is the subject of this study. The mucoid phenotype in sap27 
was restored by pMO012217 from a minimal tiling path cosmid library. The cosmid 
pMO012217 harbors 18 P. aeruginosa open reading frames (ORF). The cosmid was 
mutagenized with a transposon to map the contributing gene. It was mapped to lptD 
(PA0595) encoding lipopolysaccharide transport protein. E. coli LptD transports 
lipopolysaccharide to the outer leaflet of the outer membrane. The Alg+ phenotype was 
restored upon complementation with P. aeruginosa lptD alone, suggesting that sap27 
likely harbor a chromosomal mutation in lptD. Sequencing analysis of sap27 showed the 
 
v 
presence of a mutation not in lptD but in algO, which encodes a periplasmic protease 
protein. This suggests LptD is able to bypass an algO mutation by positively regulating 
alginate production. The lptD is a part of a three-gene operon lptD-surA-pdxA. SurA is an 
essential protein for survival in starvation and a major chaperone protein for all outer 
membrane proteins and PdxA is a NAD-dependent dehydrogenase and is involved in the 
vitamin B6 biosynthetic pathway. Pyridoxal 5’-phosphate (PLP) is the active form of 
vitamin B6. P. aeruginosa grown in a media supplemented with PLP increased production 
of pyocyanin, a virulence factor. The PLP and aromatic amino acids are synthesized from 
a common precursor chorismic acid. We demonstrated an increase in pyocyanin production 
when the bacteria were cultured supplemented by the aromatic amino acids phenylalanine. 
We concluded that the lptD operon plays a role in the P. aeruginosa virulence by regulating 
alginate and pyocyanin production.  
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CHAPTER 1 
 
 
 
 
 
Posttranslational Regulation of Antisigma Factors of RpoE: A Comparison Between the 
Escherichia coli and Pseudomonas aeruginosa 
 
Part of this introduction is published as a chapter in a book “Stress and environmental 
regulation of gene expression and adaptation in bacteria” Wiley Blackwell publication 
Sundar Pandey, Kyle Martins, and Kalai Mathee 
DOI: 10.1002/9781119004813.ch32 
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Abstract 
Pseudomonas aeruginosa, a rod-shaped Gram-negative bacterium, is an 
opportunistic human pathogen associated with skin and soft tissue infections, sepsis, and 
nosocomial infection. The bacterium can establish chronic infection and causes demise of 
people with cystic fibrosis. One of the virulence factors of the P. aeruginosa is an 
exopolysaccharide alginate. Alginate is synthesized in response to environmental 
conditions. The biosynthesis of alginate in P. aeruginosa is a highly regulated process 
where an extracytoplasmic sigma factor AlgT/U plays a key role. The increased alginate 
producing phenotype of P. aeruginosa is known as mucoid phenotype. The mechanism of 
mucoid phenotype in P. aeruginosa is extensively studied where non-mucoid to mucoid 
transition is the result of the mutation of inner membrane protein MucA. The degradation 
of MucA is a sequential process which is known as regulated intramembrane proteolysis 
(RIP). The RIP mechanism is well conserved in Gram-negative bacteria. This chapter 
describes the RIP cascade in P. aeruginosa and compares it with Escherichia coli.  
Pseudomonas aeruginosa 
In 1882, Carle Gessard isolated an organism that causes a blue-green coloration of 
wound dressings and named the microbe as Bacillus pyocyaneus, which is now known as 
P. aeruginosa (Gessard, 1882; Webster and Bernheim, 1936). The P. aeruginosa is a 
Gram-negative, rod-shaped (Figure 1.1) measuring 0.5-0.8 µm by 1.5-3.0 µm, typically 
with monotrichous flagellum and multiple pili for locomotion. 
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P. aeruginosa is a biochemically versatile microorganism that can adapt to different 
ecological niches ranging from soil, water, plants and humans (Holloway, 1955; Rahme et 
al., 1995). In hospitals, the bacterium can colonize sinks, humidifiers, respirators and 
sometimes it can be found on the hands of medical personnel (Aiello et al., 2003; Hota et 
al., 2009; Jadhav et al., 2013). P. aeruginosa is an aerobic gammaproteobacterium but it 
can grow in oxygen-limited conditions by using nitrate or arginine as the terminal electron 
acceptor (van Hartingsveldt and Stouthamer, 1973). P. aeruginosa does not usually 
establish infection in normal humans but the bacterium can become an opportunistic 
pathogen and establish disease condition in patients with impaired host defense.  It can 
cause both acute and chronic infection. 
Acute infection by P. aeruginosa 
i. Acute pneumonia in hospitalized and in particularly mechanically 
ventilated patients 
P. aeruginosa along with Staphylococcus aureus are the most common bacteria 
that cause ventilator-associated pneumonia with a high mortality rate of 13.5% 
 4 
 
(Rello et al., 1996). P. aeruginosa can contribute to community-acquired, 
hospital-acquired, and healthcare-associated pneumonia (Fujii et al., 2014). P. 
aeruginosa is associated with 92% of community-acquired pneumonia (CAP) 
with a mortality rate of 33% (Hatchette et al., 2000). In the case of CAP, 
younger patients recover better than older patients.  In fatal cases, patients die 
because of septic shock due to organ failure (Huhulescu et al., 2011; Maharaj 
et al., 2017). In cases of recovery, the complications could still arise resulting 
in parenchymal scarring and recrudescence, which require repeated antibiotic 
treatment (Maharaj et al., 2017). 
ii. Sepsis in patients with extensive burns  
Fever diarrhea, pneumonia, skin lesion, and shock are the most common 
symptom of sepsis caused by P. aeruginosa (Grisaru-Soen et al., 2000; Huang 
et al., 2002). The mortality rate of P. aeruginosa associated sepsis in children 
ranges from 20% - 50% (Huang et al., 2002). 
iii. Corneal infection in individuals wearing contact lenses 
Gram-negative bacteria and fungi are the dominant pathogens of corneal 
infection in tropical or sub-tropical climates (Lichtinger et al., 2012; Stapleton 
et al., 2012). P. aeruginosa is the most common organism in contact lens-
related disease (Stapleton et al., 2012). It has been proposed that the lens, 
storage case, and ocular environment provide a favorable niche for the survival 
of P. aeruginosa (Stapleton et al., 2012). It has been shown that exoU 
expressing phenotype is highly selected in contact-lens related corneal keratitis 
compared to non-contact lens-related keratitis (Choy et al., 2008). 
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iv. Urinary tract infection in patients with indwelling foley catheters 
P. aeruginosa causes biofilm-mediated infections that includes catheter-
associated urinary tract infections, ventilator-associated pneumonia, infections 
related to mechanical heart valves, stents, grafts, and sutures (Bharathi et al., 
2014; Bouchart et al., 1997; Chan et al., 2018; Dapas et al., 2016; Edmiston et 
al., 2013; Olejnickova et al., 2014). P. aeruginosa is responsible for 12% of all 
nosocomial urinary tract infections (Cole et al., 2014).  
v. Bacteremia and sepsis in immunocompromised patients, particularly 
neutropenic patients receiving cytotoxic therapies 
A positive correlation has been shown between P. aeruginosa and neutropenic 
patients (Lee et al., 2011; Lucas et al., 2017; Righi et al., 2017). 
vi. Post-surgical wound infection 
Post-surgical wound infection occurs after surgical operation, may originate 
during the operation or may occur after the operation from sources in the ward 
or as a result of some complications (Mousa, 1997). The increase rate of P. 
aeruginosa infection has been associated in post-operative wound infections 
(McNeil et al., 2001; Ranjan et al., 2010) 
vii.         Burn wound infection 
P. aeruginosa is the most commonly isolated from burn wounds where the 
organism can cause sepsis (Glik et al., 2017; Hsueh et al., 1998).  
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Chronic infection by P. aeruginosa 
 
Chronic infection is defined as an infection that persists in spite of therapy, and the 
host’s immune and inflammatory response (Pressler et al., 2011b). The common chronic 
lung infections caused by P. aeruginosa are in the lung of patients with chronic-
bronchiectasis, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF) 
(Finch et al., 2015; Hilliam et al., 2017; Lieberman and Lieberman, 2003; McAvoy et al., 
1989). CF and COPD have different causal origins, but they share the same relevant 
symptoms and bacterial colonization. The difference between CF and COPD patients is 
that the P. aeruginosa infections occur earlier in the case of the CF (Martinez-Solano et 
al., 2008).  
According to Leed’s criteria, chronic P. aeruginosa infection in CF patients is 
defined when >50 % of sputum cultures are positive for P. aeruginosa in the preceding 12 
months of routine checkups (Lee et al., 2003). But the Leed’s criteria are difficult to 
implement especially in young children because of the requirement of sputum samples and 
follow-up time. To solve the issue of sputum culture of P. aeruginosa it was hypothesized 
that P. aeruginosa chronic infection is associated with the dominance of the bacterium in 
the lungs while intermittently infected patients only showed low abundance of the 
pathogen. The qPCR technique can be used as good diagnostic tool to discriminate between 
intermittent and chronic infection (Boutin et al., 2018). It has been accepted that 103.4 
colony-forming units (CFU) of P. aeruginosa as a chronic infection in the lung of CF 
patients and qPCR value for the bacterium is adjusted according to the CFU (Boutin et al., 
2018). 
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Cystic Fibrosis  
Cystic Fibrosis (CF) is a debilitating autosomal recessive genetic disease that 
affects multiple organs resulting in exocrine pancreatic insufficiency in diabetes, 
malnutrition and impaired growth associated with gastrointestinal malabsorption, male 
infertility from congenital malformation of the vas deferens, and sinusitis (Coste et al., 
1995; Dray et al., 2005; Yu et al., 2012). CF is distributed worldwide (Farrell, 2008b; 
Prasad et al., 2010; Silva Filho et al., 2016; Stewart and Pepper, 2016). On the basis of live 
births, the highest incidence of the CF disease is found in Brazil especially in Euro 
Brazilians (1/1600) and the lowest incidence is found in the Japanese population 
(1/100,000-350,000) (Faucz et al., 2010; Yamashiro et al., 1997). The prevalence of the 
CF in the United States is one in 3500 and in the European Union is one in 2500 (Farrell, 
2008a). Currently, 70,000 CF patients have been registered worldwide and 30,000 in the 
United States (2016).  
Sweat glands microdissected from the skin of CF patients showed a low 
permeability of chloride ions leading to poor reabsorption of NaCl resulting in high NaCl 
concentrations in the sweat (Quinton, 1983). The inability of the sweat duct to re-absorb 
NaCl led to the identification of a defective locus on chromosome seven (Knowlton et al., 
1985; Tsui et al., 1985; Wainwright et al., 1985). Using the chromosome walking and 
jumping technique, approximately 250,000 base pairs of genomic DNA encoding the cystic 
fibrosis transmembrane conductance regulator (CFTR), a cAMP-regulated chloride ion 
channel, was identified (Riordan et al., 1989; Rommens et al., 1989). Expression of the 
cftr gene in recombinant baculovirus led to the confirmation of the role of CFTR in anion 
channel regulation (Kartner et al., 1991).  
 8 
 
The lack of functional CFTR at the apical membrane of a secretory epithelial cell 
results in defective Cl- and bicarbonate secretion, increase Na+ absorption and mucus 
secretion that leads to dehydration and acidification of the airway surface liquid (Chen et 
al., 2010; Darch et al., 2015; Tang et al., 2012). These impaired mucociliary clearance that 
provokes recurrent infection and uncontrolled inflammation resulting in lung damage, the 
primary cause of morbidity and mortality of people with CF (Boucher, 2007; Stoltz et al., 
2015).  
The CFTR protein is composed of 1,480 amino acids (aa) and 2026 different cftr 
mutations are classified (Riordan et al., 1989). Classification of cftr mutation on the basis 
of therapeutic outcome is recently proposed (De Boeck and Amaral, 2016; Marson et al., 
2016). Based on clinical features classes I, II, and III are classified as more-severe disease 
whereas classes IV, V, and VI are grouped as less-severe (Marson et al., 2016). But for 
simplicity, this dissertation adopts the cftr mutation based on the biological defect (Figure 
1.2).(Veit et al., 2016).  
1. The Class I defect results from frameshift, splicing, or non-sense mutations that 
introduce premature termination codons which cause the expression of CFTR 
to be severely reduced or absent.  
2. Class II defects encompass mutations that lead to misfolding and/or premature 
degradation in the endoplasmic reticulum. The defective protein biogenesis 
causes a highly reduced number of CFTR molecules on the secretory epithelial 
cell surface (Bombieri et al., 2015). 
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3. Class III mutants have abnormal gating that is characterized by reduced open 
probability (CFF, 2011; Marson et al., 2016; Veit et al., 2016). 
4. Class IV mutant of CFTR has altered channel conductance because of 
impedance in the ion conduction pore ultimately leading to a reduced unitary 
conductance (CFF, 2011; Hammerle et al., 2001; Marson et al., 2016; Sheppard 
et al., 1993; Veit et al., 2016). 
Figure 1.2. Classification of CF mutations based on their cellular phenotype. Class I: 
protein synthesis defect; class ll: maturation defect; class lll: gating defect; class IV: 
conductance defect; class V: reduced quantity; and class Vl: reduced stabitlity. ER, 
endoplasmic reticulum; TGN, trans-Golgi network. Courtesy (Veit et al., 2016) 
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5. Class V type CFTR has altered promoter or splicing abnormalities resulting in 
protein abundance that do not change the conformation (CFF, 2011; Haardt et 
al., 1999; Highsmith et al., 1997; Marson et al., 2016; Silvis et al., 2003; Veit 
et al., 2016; Zielenski and Tsui, 1995). 
6. Class Vl a mutation, which reduces the conformational stability of the CFTR in 
post-endoplasmic reticulum and/or at the plasma membrane (Sheppard et al., 
1993:Hammerle, 2001 #592). In addition, class VI type mutation generates 
additional internalization signals. Because of defective cftr gene, dehydrated 
mucus layer builds up in an epithelial layer that impairs mucociliary clearance 
that is a characteristic feature of patients with CF (Cohen and Prince, 2012). 
The lack of mucociliary clearance causes the gradual thickening of mucus, 
which eventually leads to the mucus plugs formation. The mucus plugs not only 
Figure 1.3. The most common microbes found in lung of CF. Relationship shows 
inverse relationship between mucoid P. aeruginosa and lung function predicted by 
forced expiratory volume 1 (FEV1). FEV1 indicates severity in lung function. Courtesy 
(Pier, 2000). 
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obstruct the airways but also create oxygen gradient from hypoxic to anoxic 
regions (Worlitzsch et al., 2002). The environment is made further anoxic 
because of the growth of P. aeruginosa where the bacterium uses nitrates and 
nitrites as terminal oxygen accepter (Worlitzsch et al., 2002). Furthermore, P. 
aeruginosa decreases the apical expression of cftr gene (MacEachran et al., 
2007; Rubino et al., 2014; Trinh et al., 2015). Oxygen availability, 
inflammation, and microbial communities are heterogeneous in CF lung that 
affects the host microbial interaction and eventually the disease progression. 
Microbial communities in CF airways 
The Streptococcus, Veillonella, and Prevotella are the dominant genera in a healthy 
lung (Li et al., 2016). But, bacterial species like Haemophilus influenzae, S. aureus, P. 
aeruginosa, Burkholderia cepacia, Alcaligenes xylosoxidans, Klebsiella spp., some 
pathogenic virus like respiratory syncytial virus and adenoviruses, and the fungi 
Aspergillus and Candida species are commonly found in CF airways (Haase et al., 1991; 
Lambiase et al., 2006; Nixon et al., 2001; Scoffone et al., 2017; van Ewijk et al., 2008; 
Willger et al., 2014). In CF pediatric samples, Streptococcus, Haemophilus, 
Staphylococcus, and Achromobacter predominant whereas and in adult Pseudomonas, 
Burkholderia, Streptococcus, Haemophilus, and Staphylococcus are the dominant genus. 
P. aeruginosa becomes dominant pathogen as the increase in the age of people with CF 
(Figure 1.3). Rothia, Preovtella, Gemella, Actinomyces, and Veillonella are prevalent in 
both pediatric and adult samples (Coburn et al., 2015). One of the methods that is used to 
assess the lung disease status of the individual with cystic fibrosis is forced expiratory 
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volume in one sec (FEV1). FEV1 is the quantity of air that can be forcibly exhaled from 
the lungs in first one second. The ratio of FEV1 of CF individual and FEV1 of reference 
population is %FEV1 that indicates the health status of a lung of people with CF (Wang et 
al., 1993). It was observed that the FEV1 ratio of individual with CF is lower indicating 
the decline function of the lung (Pier, 2000)(Figure 1.3).  
 
Genotypic change in P. aeruginosa in CF lung 
P. aeruginosa, during infection of CF airways, undergo evolution and adaptation 
(Figure 1.4) (Ciofu et al., 2010). The adaptive phenotypes include increased alginate 
production, loss of quorum-sensing, motility, effector proteins of the type lll secretion 
system, and loss of the O-antigen component of the lipopolysaccharide, reduce virulence, 
reduced capacity of the non-mucoid phenotype for in vitro biofilm formation (Cigana et 
Figure 1.4. Common mutations in P. aeruginosa CF isolates. Genes encoding 
regulatory proteins are highlighted in red. The phenotype that is of interest of this 
dissertation is shown in box with blue color. Courtesy (Winstanley et al., 2016) 
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al., 2016; Ciofu et al., 2010; Cullen et al., 2015; Oliver et al., 2000; Smith et al., 2006; 
Warren et al., 2011; Williams et al., 2018; Workentine et al., 2013). It is important to 
understand that both environmentally-acquired strains and patient-to-patient transmissible 
strains of P. aeruginosa appear to have a similar genomic mutation that provides an 
adaptive advantage in the lung of CF patient (Fothergill et al., 2012; Jelsbak et al., 2007; 
Williams et al., 2018). One study showed that the genotypic and phenotypic diversity could 
also be the result of recombination and not always the result of the spontaneous mutations 
occurs in the P. aeruginosa (Darch et al., 2015).  
One of the genotypic and phenotypic changes that is of interest of this dissertation 
is an emergence of mucoid colonies caused by increased production of alginate (Carlson 
and Matthews, 1966). Along with alginate two other polysaccharide (Pel and Psl) play a 
role in the development and structural maintenance of biofilm of P. aeruginosa (Colvin et 
al., 2012; Stapper et al., 2004).  
 
Figure 1.5. Alginate composition. The O-acetylation occurs in mannuronic acid. The ß-
1,4-glycosidic bond link the guluronic and mannuronic acid. Courtesy (Franklin et al., 
2011) 
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Alginate 
Alginate is an exopolysaccharide, meaning it is not covalently linked to the 
bacteria, composed of non-repeating unit of O-acetylated β-D-mannuronic (M) acid 
residues randomly interspersed with its C5’ epimer α-L-guluronic acid (G) residues by 1,4-
glycosidic bonds (Figure 1.5)(Chitnis and Ohman, 1990; Schurks et al., 2002; Skjakbraek 
et al., 1986). The alginate of P. aeruginosa is composed of random blocks of MM and MG 
residues. In P. aeruginosa FRD1, a sputum mucoid isolate from a CF patient, the molar 
ratio of mannuronic acid and guluronic acid was found to be 2:1 (Schurks et al., 2002). 
Acetylation of alginate promotes the cell aggregation, confers elasticity, and provides 
resistance to the opsonic killing of P. aeruginosa (Moradali et al., 2015; Pier et al., 2001; 
Wloka et al., 2004). Alginate is not required but it affects the formation of biofilm (Hentzer 
et al., 2001; Stapper et al., 2004). Antibiotics, high osmolarity, dehydration, and release of 
hydrogen peroxide by polymorphonuclear cells have all been shown to promote alginate 
production (Berry et al., 1989; Devault et al., 1990; Govan and Fyfe, 1978; Mathee et al., 
1999).  Alginate protects P. aeruginosa from an oxidative burst from the immune system; 
provides an advantage for adherence to an extracellular material, antibiotic tobramycin, 
and protection from phagocytes (Hentzer et al., 2001; Leid et al., 2005; Tielen et al., 2005). 
It has been shown that alginate-deficient P. aeruginosa develops biofilm but with a reduced 
number of viable cells compared to alginate-producing P. aeruginosa (Ghafoor et al., 
2011). Free radicals produced by macrophages and neutrophils cannot depolymerize nor is 
the alginate degraded during phagocytosis suggesting alginate is helpful for bacterial 
survival in CF lung (Simpson et al., 1989). It is interesting that the mucoid P. aeruginosa 
isolated from chronic CF adults is less resistant than non-mucoid isolated against 
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antibiotics colistin, tobramycin, meropenem, and ciprofloxacin suggesting the presence of 
a secondary mutation. 
The high amount of immunoglobulin G (IgG) is mounted against the alginate in 
chronically affected CF patients but such IgG is ineffective to clear P. aeruginosa infection 
(Mauch et al., 2017; Meluleni et al., 1995).  
Biosynthesis of alginate  
Alginate biosynthesis requires multiple gene products (Figure 1.6) (Table 1.1). The 
algD operon (algD8alg44algKalgEalgGalgXalgLalgIalgJalgFalgA) and other gene, algC, 
which is not encoded in the algD operon, are required for alginate biosynthesis in P. 
aeruginosa (Table 1.1) (Chitnis and Ohman, 1993; Shortridge et al., 1991). For alginate 
biosynthesis, the carbon is funneled from fructose 6-phosphate that is converted to 
mannose 6-phosphate by AlgA (Darzins et al., 1986; Shinabarger et al., 1991). Then, AlgC, 
a phosphomannomutase isomerizes mannose 6-phosphate to mannose 1-phosphate 
(Zielinski et al., 1991). Other protein AlgA then converts mannose 1-phosphate to GDP-
mannose by AlgA (May et al., 1994). Then, AlgD oxidizes GDP-mannose to GDP-
mannuronate (Roychoudhury et al., 1989). For the synthesis of alginate, D-mannuronic 
acid is polymerized by the inner membrane protein Alg8, and copolymerase, Alg44 
(Merighi et al., 2007; Remminghorst et al., 2009; Remminghorst and Rehm, 2006). Then 
AlgI, AlgJ, and AlgF play roles in the acetylation of the polymer (Franklin and Ohman, 
1996; Shinabarger et al., 1993).  The O-acetylation of alginate occurs only on mannuronate 
residues (Davidson et al., 1977).   
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After acetylation of the mannuronate residues, the AlgG epimerizes the non-
acetylated D-mannuronic acid residues into the L-guluronic acid (Franklin et al., 1994). 
Still, it is not known whether epimerization occurs prior to or after acetylation. 
Physiologically the acetylation of alginate increases the overall gel volume that might 
protect P. aeruginosa from dehydration (Skjakbraek et al., 1989). Immunologically O-
acetylation of alginate protects the bacterium from neutrophils and lymphocytes (Mai et 
al., 1993).  
Figure 1.6. A proposed model of alginate biosynthesis. AlgA, AlgC, and AlgD construct 
the alginate monomers in the cytosol of the P. aeruginosa. Polymerization, acetylation, 
and epimerization occur in periplasm, and AlgE is responsible for exporting the polymer 
to the extracellular environment (Franklin et al., 2011; Moradali et al., 2015; Ramsey and 
Wozniak, 2005). 
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Regulation of alginate biosynthesis in P. aeruginosa 
The 12 gene algD operon is positively regulated by an alternate sigma factor 
AlgT/U (Wozniak and Ohman, 1994). The algD promoter contains a large 367-bp leader 
region between the transcription start site and translation start codon (Wurtzel et al., 2012). 
The direct SELEX enrichment approach showed AlgB binds 50 bp located at -274 to -224 
upstream relative to algD transcription site, which is 367 bp upstream of algD translation 
start site (Leech et al., 2008). It has been also shown that AlgT/U activates algR and algB 
both of which positively regulate algD transcription (Leech et al., 2008; Wozniak and 
Ohman, 1994). 
Alginate R (AlgR) is homologous to response regulator that has atypical sensor 
kinase FimS (formally known as AlgZ) whereas AlgB-KinB forms two-component system 
(Deretic et al., 1989; Ma et al., 1997a; Yu et al., 1997). AlgR has two major structural 
domains, an N-terminal CheY-like receiver domain, and carboxyl DNA-binding domain 
of the LytR/YehT/AgrA family of a transcriptional regulator (Kato and Chakrabarty, 1991; 
Mohr et al., 1991; Mohr et al., 1992). Overexpression of AlgR represses algD transcription 
and alginate production (Deretic and Konyecsni, 1989). Both AlgB and AlgR do not 
require phosphorylation of the conserved aspartic acid residue in the regulatory domain to 
promote alginate production in mucoid P. aeruginosa (Ma et al., 1998). Chromosome 
immunoprecipitation analysis showed AlgB directly binds to the algD promoter (Leech et 
al., 2008).  
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Table 1.1 Genes associated with alginate biosynthesis 
Gene                 Function References 
 Alginate biosynthesis  
algA Phosphomannose isomerase and GDP- 
mannose pyrophosphorylase activity                                                                  
 (Shinabarger et al., 1991) 
algC Phosphomannomutase and 
phosphoglucomutase activities; involved 
in LPS biosynthesis  
(Regni et al., 2004; Zielinski et 
al., 1991) 
algD GDP-mannose dehydrogenase (Snook et al., 2003; Tatnell et 
al., 1993) 
algE Outer membrane, alginate-specific ion 
channel responsible for alginate export 
(Chu et al., 1991; Grabert et al., 
1990) 
algF Periplasmic protein involved in alginate 
O-acetylation 
(Franklin and Ohman, 1993; 
Franklin and Ohman, 2002) 
algG Periplasmic associated, C5-mannuronan 
epimerase; protects alginate polymer 
from lyase activity  
(Franklin et al., 1994; Jain et 
al., 2003) 
algI Inner membrane protein involved in 
alginate O-acetylation 
(Franklin and Ohman, 2002) 
algJ Membrane-associated, periplasmic 
protein involved in alginate O-
acetylation 
(Franklin and Ohman, 2002) 
algK Periplasmic protein required for proper 
polymer formation 
 (Aarons et al., 1997; Jain and 
Ohman, 1998) 
algL Periplasmic alginate lyase (Monday and Schiller, 1996; 
Schiller et al., 1993) 
algX Periplasmic protein required for proper 
polymer formation 
(Monday and Schiller, 1996; 
Robles-Price et al., 2004) 
alg8 Membrane protein, alginate polymerase (Maharaj et al., 1993) 
algB Positive activator of algD transcription (Goldberg and Dahnke, 1992; 
Wozniak and Ohman, 1991) 
kinB Inner membrane protein; cognate sensor 
kinase for AlgB 
(Ma et al., 1997b) 
fimS Hypothesized cognate sensor kinase for 
AlgR; positively activator of type IV-
mediated twitching motility 
(Whitchurch et al., 1996; Yu et 
al., 1997) 
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algR Positively activates algC and algD 
transcription 
(Deretic et al., 1989; 
Nikolskaya and Galperin, 2002) 
sspA Hypothesized that it reduces transition 
of RpoD associated genes 
(Yin et al., 2013) 
RpoN Required for AlgT/U activity in kinB 
null mutant  
(Damron et al., 2009) 
clpXP Facilitated degradation of mutant MucA (Qiu et al., 2008b) 
 
Other regulators of the algD operon is alginate and mobility regulator Z (AmrZ) 
(Baynham and Wozniak, 1996; Xu et al., 2016). AmrZ has three segments a flexible N-
terminus [1-11], a ribbon-helix-helix domain [12-66] and C-terminus [67-108]. Using 
Chip-Seq and electrophoretic mobility shift assay (EMSA), AmrZ-binding site (ZBS) in 
algD promoter was found around nucleotides -312(ZBS1), -289(ZBS2), -13(ZBS3) and, -
75(ZBS4) upstream relative to the algD transcription start site of algD (Xu et al., 2016). 
Transcriptional activation of algD requires at least 57 bp of DNA between ZBS1 and ZBS2 
(Xu et al., 2016). AmrZ binds 8 bp to a direct repeat [GCCATTAC], but a mutation within 
the repeat results in a four-fold decrease in AmrZ binding and 28-fold decrease in algD 
transcription (Baynham and Wozniak, 1996).  
Another protein, the integration host factor (IHF) encoded by himA and himD, of 
P. aeruginosa is an αβ heterodimer, which through electrophoretic mobility shift assay 
(EMSA) it was shown that the IHF forms a stable complex with the algD promoter (Mohr 
and Deretic, 1992; Toussaint et al., 1993). There are two IHF binding sites on the algD 
promoter, one between -80 to -68 and another between 79 to 105 relative to the 
transcription initiation site of algD mRNA. The amount of alginate in IHF mutant cell is 
half [200 μg/ mg dry cell wt] compared to wild-type P. aeruginosa [400 μg/ mg dry cell 
wt] (DelicAttree et al., 1996).  
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Additionally, MucR an inner membrane-anchored protein positively regulates the 
alginate biosynthesis in P. aeruginosa by increasing the level of cyclic-di-GMP in the 
cytoplasm (Hay et al., 2009). 
AlgT/U regulates the expression of algT, algD, algR, algB, algZ, algC (Devries and 
Ohman, 1994b; Hershberger et al., 1995; Martin et al., 1994; Wozniak and Ohman, 1994; 
Zielinski et al., 1991). Alginate production is a metabolically expensive process and to 
synthesize one set of all proteins for the alginate biosynthesis and production, it requires at 
least 348,984 GTPs. The required GTP number calculation is only for the protein synthesis. 
Additionally, the amount of GTP required to the synthesis of alginate molecule itself is yet 
to be calculated.  
Alginate production is energetically expensive thus regulation in alginate 
production is very controlled transcriptionally by autoregulation of sigma factor AlgT/U 
and post transcriptionally by sequestration of AlgT/U by anti-sigma factor MucA. The 
release of AlgT/U from MucA is by the process known as regulated intramembrane 
proteolysis (RIP) that involves series of periplasmic and inner membrane proteases.  
In this chapter, genes involved in regulation of alginate production in P. aeruginosa 
are discussed and compared with the genes in E. coli because of the similarity of the 
pathways between the two bacteria (Ades et al., 1999; Qiu et al., 2007). 
Regulated intramembrane proteolysis cascade 
The RpoE homologs function as extracytoplasmic sigma factors (Rowen and 
Deretic) (Lonetto et al., 1994). The stress signals initiate a proteolytic cascade that 
eliminates an inner membrane negative-regulator i.e., an anti-sigma factor, freeing RpoE.  
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The RIP cascade is common to many bacteria, including Bacillus subtilis (Schobel et al., 
2004; Zellmeier et al., 2006), Mycobacterium tuberculosis (Sklar et al., 2010), and 
Xanthomonas campestris (Bordes et al., 2011). The following section will investigate the 
role of the major players involved in the P. aeruginosa and E. coli RIP cascade (Table 1.1) 
and the signals involved. For simplicity, the nomenclature in column 2 and column 6 of 
the Table 1.2 will be adopted in this chapter. Although the members of the E. coli and P. 
aeruginosa RIP cascade are functionally conserved, there is a wide variation in sequence 
homology between gene orthologs (Table 1.3).  
Extracytoplasmic stress sigma factor σE: AlgT/U and RpoE  
P. aeruginosa and E. coli RpoE share 66 % homology (Lonetto et al., 1992).  E. 
coli RpoE has been found to restore the mucoid (Alg+) phenotype in algT/U mutant P. 
aeruginosa (Yu et al., 1995). However, there is no in vivo experimental evidence as to 
whether algT/U complements the function of rpoE in E. coli; although AlgT/U has been 
shown to transcriptionally activate E. coli RpoE-dependent promoters in vitro 
(Hershberger et al., 1995). Activation of alternative sigma factors in P. aeruginosa and E. 
coli is controlled both at the level of transcriptional initiation and post-translation. The 
rpoE operon contains four genes, which either positively or negatively regulate its activity 
in E. coli (Missiakas et al., 1997).  The three open reading frames downstream of rpoE 
encode regulators of sigma E and are thus named rseA, rseB, and rseC (De Las Penas et 
al., 1997; Missiakas et al., 1997). In the case of P. aeruginosa, algT/U is a part of a five-
gene operon containing algT/U, mucA, mucB, mucC, and mucD (Boucher et al., 1996; 
Franklin and Ohman, 1996). These Muc proteins regulate AlgT/U activity. 
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E. coli RseA and P. aeruginosa MucA – the anti-sigma factors 
Both regulator of sigma E (Rse) A (RseA) and Mucoid A (MucA) are negative 
regulators of the alternative sigma factors RpoE and AlgT/U, respectively, and are referred 
to as anti-sigma factors. For more details, analyses of other anti-sigma factors are reviewed 
previously (Hughes and Mathee, 1998).  Though these two proteins are functional 
equivalents, they share very little sequence homology (Table 1.3). Transposon insertions 
in rseA resulted in a 12-fold increase whereas deletion mutants exhibited a 25-fold 
induction of RpoE activity  (De Las Penas et al., 1997; Missiakas et al., 1997). The large 
up-regulation upon the loss of rseA suggested that the major role of RseA is to act as a 
negative regulator of RpoE activity.  Inactivation of mucA in P. aeruginosa resulted in a 
mucoid phenotype suggesting that MucA is a negative regulator of alginate production 
(Fyfe and Govan, 1980; Govan and Fyfe, 1978; Martin et al., 1993a; Mathee et al., 1999). 
Mapping and sequence analysis showed that mucA was located directly downstream of 
algT/U (Martin et al., 1993a). 
Both RseA and MucA are localized to the inner membrane with the N-terminus in 
the cytoplasm and C-terminus in the periplasm (De Las Penas et al., 1997; Lewenza et al., 
2005; Mathee et al., 1997; Missiakas et al., 1997). Membrane preparations of RseA-
overproducing bacteria showed RpoE co-eluted with RseA (Missiakas et al., 1997). 
Pull-down experiments using RpoE-specific antibodies showed RseA and RpoE 
co-immunoprecipitating at a molar ratio close to 1:1 (Missiakas et al., 1997). In case of P. 
aeruginosa, co-expression of MucA and AlgT/U followed by cross-linking (Boucher et al., 
1996) suggested MucA and AlgT/U interact directly. The interaction of MucA and AlgT/U 
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is was supported by the co-fractionation of MucA and AlgT/U in glycerol sedimentation 
experiments (Xie et al., 1996). 
E. coli RseB and P. aeruginosa MucB – Anti-anti sigma factors 
RseB and MucB share only 27.6% homology (Table 1.3), however, they are functional equivalents 
that interact with the anti-sigma factors and subsequently affect alternative sigma factor activity. 
Deletion of rseB in E. coli resulted in an increase in rpoE expression; whereas loss of mucB resulted 
in alginate production (Goldberg et al., 1993; Martin et al., 1993a). These findings clearly argued 
that RseB and MucB are negative regulators of RpoE and AlgT/U, respectively. Both RseB and 
MucB were localized to the periplasm (Boucher et al., 1996; Mathee et al., 1997; Missiakas et al., 
1997). Direct interaction between RseB and MucB with their cognate anti-sigma factors RseA and 
MucA, respectively, has been demonstrate   (Missiakas et al., 1997; Rowen and Deretic, 2000).  
Specifically, RseB and MucB were found to interact with the periplasmic C-
terminal domain of their cognate anti-sigma factors (Cezairliyan and Sauer, 2007; Wood 
and Ohman, 2009). RseB is present as a dimer that protects RseA from cleavage by DegS 
(Wollman and Zeth, 2007; Cezairliyan and Sauer, 2007). In the case of MucB, it exists in 
both monomeric and dimeric forms, however; only the dimer binds to MucA (Cezairliyan 
and Sauer, 2009). The RseA-RseB interaction appears to stabilize RseA and strengthens 
RseA’s bond with RpoE (Ades et al., 1999; Collinet et al., 2000). 
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                  Table 1.2. List of proteins involved in RpoE regulation 
 
P. aeruginosa E. coli 
Product 
Name Locus 
Tag 
Protein 
Alternative 
Name 
Size 
(aa) 
Locus 
Tag 
Protein 
Alternative 
Name 
Size 
(aa) 
PA0762 AlgT/U RpoE/σ22 193 ECK2571 RpoE σ24/ σE/SigE 191 
Sigma 
factor 
PA0763 MucA  194 ECK2570 RseA MclA/YfiJ 216 
Anti-sigma 
factor 
PA0764 MucB AlgN 316 ECK1569 RseB MclB 318 
Negative 
regulator 
PA0765 MucC AlgM 151 ECK2568 RseC MclC 159  
PA0766 MucD AlgY/HtrA 474 ECK0160 DegP HtrA/Ptd/Do 475 
Serine 
endoprotease 
PA4446 AlgW  389 ECK3224 DegS HhoB/HtrH 355 
Site 1 protease; 
HtrA family 
PA3649 MucP  450 ECK0175 RseP YaeL/EcfE 450 
Site 2 protease; 
Zn dependent 
PA4033 MucE  89 
No 
homologs 
    
PA1802 ClpX ClpX 426 ECK0432 ClpX  424 
ATPase subunit 
of the protease 
PA1801 ClpP Clp1 213 
ECK0431 ClpP LopP/WseA 201 
Proteolytic 
subunit of the 
protease PA3326 Clp2  201 
PA4427 SspB  135 ECK3217 SspB  165 
Stringent 
starvation 
protein 
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Table 1.3. Comparison of E. coli and P. aeruginosa homologs involved in the anti-sigma factor (RseA 
and MucA, respectively) proteolysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The numbers refer to percentage homology as determined using ClustalW (Table 1.3). The shaded boxes 
compare the functional homologs. The protein sequences of E. coli and P. aeruginosa were retrieved from 
ecogene.com and pseudomonas.com. 
 
 
 
 
 
 
 
 
E. coli K12 
RpoE RseA RseB RseC DegP DegS RseP ClpX ClpP SspA SspB 
P
. 
a
er
u
g
in
o
sa
 P
A
0
1
 
AlgT/U 66.0 7.8 18.7 15.2 20.7 18.8 21.2 25.4 16.2 9.3 15.7 
MucA 14.4 28.3 22.2 18.2 16.1 15.0 18.6 17.0 13.3 14.9 13.3 
MucB 19.4 16.2 27.6 29.9 17.2 11.4 19.5 18.4 17.0 19.3 18.1 
MucC 15.9 17.2 21.2 30.0 23.2 26.5 24.5 22.5 10.7 17.3 13.3 
MucD 22.0 19.4 17.9 15.0 39.2 33.4 15.4 15.2 23.2 16.9 19.3 
AlgW 17.4 17.6 15.8 23.9 36.8 46.3 17.2 14.3 20.3 18.4 18.7 
MucP 17.3 17.6 19.8 23.2 10.2 16.7 46.9 11.9 17.9 23.5 22.4 
ClpX 23.0 15.3 15.1 19.5 16.2 17.9 12.6 76.6 19.3 21.2 17.5 
ClpP 12.0 11.3 16.1 18.9 18.8 17.4 19.7 17.4 69.6 13.2 14.5 
ClpP2 16.2 12.6 19.4 19.6 14.9 19.4 16.4 22.6 41.5 14.2 15.7 
SspA 13.2 11.5 20.0 20.1 18.6 17.6 19.5 21.2 12.6 53.9 15.2 
SspB 16.3 19.2 20.0 18.0 21.5 20.8 22.2 18.5 16.3 20.0 53.3 
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Coaggregation of RseB with misfolded proteins suggests that it may act as a stress 
sensor, which may allow RseB to release from RseA to initiate the RIP cascade leading to 
RpoE-dependent activity (Collinet et al., 2000). 
E. coli RseC and P. aeruginosa MucC  
Though both E. coli rseC and P. aeruginosa mucC are the third gene in their 
respective rpoE operons, they share only 30% homology. The role of RseC and MucC is 
ambiguous and little is currently known about the exact cellular function of these members 
of the rpoE and algT/U operons (Boucher et al., 1997a; De Las Penas et al., 1997; Franklin 
and Ohman, 1996; Missiakas et al., 1997). 
E. coli DegP and P. aeruginosa MucD 
E. coli degradation protein P (DegP) that is required for growing the bacterium 
above 42 C and P. aeruginosa Mucoid D (MucD) share 39% homology (Table 
1.3)(Gottesman and Zipser, 1978; Strauch et al., 1989b).  The presence of mucD in the 
algT/U operon suggests that MucD should play a role in the post-translational regulation 
of AlgT/U. In the case of E. coli, degP is not present in the rpoE operon (Strauch and 
Beckwith, 1988). Expression of both degP and mucD are under the control of RpoE and 
AlgT/U, respectively (Boucher et al., 1996; Dartigalongue et al., 2001; Erickson and 
Gross, 1989; Franklin and Ohman, 1996; Lipinska et al., 1988; Wang and Kaguni, 1989).  
Though mutations in degP had no effect on E. coli rpoE transcription, DegP is 
required for its growth at elevated temperatures (Lipinska et al., 1989; Lipinska et al., 
1990). Both null and point mutations of mucD in non-mucoid PAO1 resulted in a mucoid 
phenotype conversion (Boucher et al., 1996; Wood et al., 2006). Alkaline-phosphatase 
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fusions of DegP and MucD showed them to be localized to the periplasm (Lewenza et al., 
2005; Strauch et al., 1989a). The major role of both DegP and MucD is to degrade 
misfolded proteins from the periplasm (Strauch and Beckwith, 1988; Wood and Ohman, 
2009) that may indirectly regulate RseB and MucB allowing it to re-interact with their 
cognate anti-sigma factors.  
 E. coli DegS and P. aeruginosa AlgW  
The degradation protein S (DegS) and Alginate W (AlgW) share substantial 
homology (Table 1.3). They are also members of the HtrA family of serine proteases 
(Pallen and Wren, 1997). DegS and AlgW are also known as Site-1 proteases (S1P), which 
cleave anti-sigma factors on their periplasmic sides (Dalbey et al., 2012; Qiu et al., 2007).   
DegS is an inner membrane protein with a large periplasmic domain (Alba et al., 
2002); (Waller and Sauer, 1996). Based on sequence homology, AlgW is also presumed to 
be an inner membrane protein with a single transmembrane domain. DegS initiates the first 
cleavage of RseA leading to an eventual release of RpoE to initiate transcription (Ades et 
al., 1999; Alba et al., 2002). DegS cleaves between amino acids Val148 and Ser149 in the 
transmembrane domain of RseA adjacent to the periplasmic side (Walsh et al., 2003). 
AlgW primarily cleaves MucA between amino acids Ala136 and Gly137 (Cezairliyan and 
Sauer, 2009).  DegS binding of the C-terminal -YXF motif of misfolded OMPs activates it 
to cleave RseA (Walsh et al., 2003). But, in P. aeruginosa, mucE that encodes an outer 
membrane associated small protein bind with a specific C-terminal -WVF motif and 
initiates RIP cascade (Qiu et al., 2007).  
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E. coli RseP and P. aeruginosa MucP 
Both RseP and MucP are Site-2 Proteases (S2P) which are membrane-bound zinc 
metalloproteinases involved in the proteolytic activation of regulatory factors for sterol 
biosynthesis and for stress responses (Kanehara et al., 2001; Kinch et al., 2006; Qiu et al., 
2007). RseP and MucP were both identified based on sequence homology to other site-2-
proteases (Kanehara et al., 2001; Qiu et al., 2007). RseP is essential in E. coli as depletion 
causes a rapid loss of viability, cell elongation, and growth cessation (Kanehara et al., 
2001). 
RseP is an inner membrane protein with four transmembrane domains with both 
the N- and C- termini lying in the periplasm (Kanehara et al., 2001).  RseP also contains 
two periplasmic PDZ domains involved in its regulation (Inaba et al., 2008); (Kanehara et 
al., 2003). Our analysis using TMHMM shows MucP possessing a similar domain structure 
to RseP. Cleavage of RseA by RseP was confirmed using in vitro assays (Akiyama et al., 
2004).  The regulated proteolysis of RseA requires a functional PDZ domain of RseP 
(Kanehara et al., 2003). Indirect genetic evidence for MucP cleavage of MucA leading to 
AlgT/U expression has been shown using mutant strains (Damron et al., 2011; Qiu et al., 
2007). No direct interaction with MucP and MucA has been demonstrated. 
E. coli and P. aeruginosa ClpXP  
After RseP-cleavage of RseA, a small fragment of RseA remains attached to RpoE 
(De Las Penas et al., 1997; Missiakas et al., 1997). The removal of this RseA cytoplasmic 
fragment requires SspB and ClpXP (Flynn et al., 2004). SspB was found to bind to both 
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the amino-terminus of RseA as well as ClpX thereby bringing the fragment close enough 
to the ClpXP protein complex to allow for RseA fragment degradation (Flynn et al., 2004). 
In P. aeruginosa, there are two ClpP homologs, ClpP (PA1801) and ClpP2 
(PA3326). Mutagenesis of clpX, clpP, and clpP2 individually resulted in the loss of a 
mucoid phenotype (Qiu et al., 2008a). P. aeruginosa also harbors the sspAB (PA4426-
PA4427) operon (Yin et al., 2013).  Unlike E. coli, SspA appears to play a role in alginate 
production (Yin et al., 2013). A direct interaction between the MucA fragment and ClpXP 
or SspA has yet to be demonstrated.   
RIP Models for E. coli and P. aeruginosa 
Many questions remain unanswered. However, on the basis of the above findings, 
the following model is proposed for E. coli (Figure 1.7A). and P. aeruginosa (Figure 1.7B). 
E. coli RIP cascade 
Misfolded OMP peptides with exposed C-terminal -YQF motifs bind to the PDZ 
domain of DegS allowing cleavage of RseA at the periplasm. It is also presumed that 
misfolded peptides compete for binding with RseB from RseA allowing cleavage of RseA 
by DegS. Alternatively, it has been postulated that RseB hinders RseP-recognition of RseA. 
Following cleavage by DegS, RseP cleaves RseA at the cytoplasm releasing RpoE with an 
N-terminal fragment of RseA. This N-terminal fragment of RseA remains attached until 
removed by SspB-ClpXP releasing the free RpoE to initiate transcription of the RpoE 
regulon.  
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P. aeruginosa RIP cascade 
Similar to the E. coli system, MucA is sequentially degraded by AlgW, and MucP. 
The C-terminal -WVF motif of MucE has been shown to prime the AlgW protease to 
initiate the cleavage of MucA. The direct cleavage of MucA by MucP, or interaction of 
ClpXP or SspA/B has not been demonstrated but inferred from genetic data and by 
comparison to the E. coli system. In P. aeruginosa SspB appears to play a role in this 
pathway. Free AlgT/U activates all the genes in the alg regulon, leading to alginate 
production. 
Inducers of alginate production 
 Chemical 
Ammonium metavanadate  
Pseudomonas isolation agar supplemented with ammonium metavanadate [0.27 mM] 
induces alginate production in P. aeruginosa (Damron et al., 2011). Growing P. 
aeruginosa in ammonium metavanadate increases the expression of periplasmic stress 
chaperones MucD and well as cytoplasmic chaperones GroEL [PA4385], DnaK [PA4761], 
GrpE [PA4762]; and outer membrane proteins [OMP] OprF [PA1777], and OprO 
[PA3280] but exactly how the chemical induces the mucoid phenotype is not clear yet 
(Damron et al., 2011). The mucoid P. aeruginosa grown on pseudomonas isolation agar 
(Imperi et al.) supplemented with ammonium metavanadate when streaked back to PIA, 
the mucoid P. aeruginosa turned non-mucoid suggesting ammonium metavanadate based 
mucoid phenotype is not due to the genetic change in the bacterium (Damron et al., 2011). 
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Figure 1.7. Proposed model for the anti-sigma factor proteolysis in E. coli (A) and P. 
aeruginosa (B). The model is based on currently available data. (A) The steps for E. coli 
are outlined as follows: (i) –YXF C-terminal motif exposed in misfolded OMPs binds to 
the PDZ domain of DegS activating its proteolytic domain. DegP may degrade misfolded 
OMP proteins prior to their interaction with DegS, perhaps preventing DegS activation; 
Based on P. aeruginosa system, RseB dissociates to allow site-1 proteolysis of RseA at its 
periplasmic side by DegS; (iii) The removal of C-terminal RseA allows for site-2 
proteolysis at its cytoplasmic side by RseP. It has been postulated that RseP access to RseA 
can also be prevented by RseB; (iv) RseP activity releases RpoE with a fragment of RseA 
bound to it; (v) SspB binds to and brings the RseA fragment to the ClpXP proteasome; (vi) 
ClpXP degradation of the RseA fragment releases free RpoE; (vii) Free RpoE directs RNA 
polymerase that is made of five subunits (α2ββ’ω) to initiate transcription of the RpoE 
regulon. (B) The model is based on the available data and is, in part, inferred from the E. 
coli system. The steps involved are as follows: (i) –WVF motif on MucE binds to the AlgW 
PDZ domain activating its proteolytic activity. MucD is hypothesized to inhibit the 
interaction of MucE with AlgW, as well as binding misfolded proteins; (ii) Activated AlgW 
cleaves the periplasmic domain of MucA releasing MucB along with a C-terminal fragment 
of MucA; (iii) MucP induces site-2 proteolysis of MucA at the cytoplasmic side releasing 
AlgT/U with a small N-terminal fragment of MucA attached; (iv) Based on the E. coli 
system, SspA is proposed to be the adaptor molecule that brings AlgT/U with the MucA 
fragment to ClpXP; (V) The MucA fragment is removed from AlgT/U by the ClpXP 
proteasome. The role of ClpP2 homolog is not clear; (vii) Free AlgT/U directs RNA 
polymerase to initiate transcription of the AlgT/U regulon. 
 
 
Imipenem  
Growing P. aeruginosa in biofilms upon exposure to the antibiotic imipenem [1.0 
g/ml] for 24 hours cause the appearance of a mucoid phenotype (Bagge et al., 2004). 
However, sub-culturing the mucoid P. aeruginosa from the imipenem-exposed biofilm 
on nonselective LB agar plates did not show the mucoid phenotype suggesting that the 
observed mucoidy was unstable (Bagge et al., 2004). 
Ethanol  
Mucoid P. aeruginosa were obtained when the bacterium was grown for 6 days at 
room temperature (22 ºC) on (Yeast extract, tryptone, and glucose) YTG medium 
 33 
 
supplemented with 3% - 5% ethanol (Devault et al., 1990). The frequency of mucoid 
variant formation was one colony per 106 cells but the mucoid phenotype lasted for 14 
days when grown in the same medium without ethanol before it reverted back to 
nonmucoid phenotype (Devault et al., 1990). 
Phage  
Phage was isolated from the supernatant of phage-induced-mucoid variants of P. 
aeruginosa and applied to the non-mucoid strain of P. aeruginosa, which caused the non-
mucoid strain to turn mucoid suggesting phage can also induce mucoidy in P. aeruginosa 
(Martin, 1973). 
Estradiol 
 It has been shown in both human and mouse model that estradiol enhances the 
alginate production in P. aeruginosa may be responsible for a survival disadvantage of 
female patients with CF (Chotirmall et al., 2012).  
Mucoid phenotype and antibiotic resistance of P. aeruginosa 
It has been proposed that alginate production contributes to antibiotic resistance in 
P. aeruginosa, but several results show that there is no correlation between mucoidy and 
antibiotic resistance. There is no significant effect of the antibiotics tobramycin and 
tigecycline to the wild-type PAO1 and mucoid P. aeruginosa (Oglesby-Sherrouse et al., 
2014). 
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Stability  
It is commonly known that mucoid clinical P. aeruginosa reverts to the non-mucoid 
phenotype (Govan, 1975; Zierdt and Schmidt, 1964). For the clinical P. aeruginosa FRD 
strain, incubation of the strain in L-broth at 40 °C without aeration results in mucoid to 
non-mucoid conversion at the rate of 50% within 24 – 48 hours (Ohman and Chakrabarty, 
1981). Mucoid to non-mucoid conversion is faster when the bacteria are grown without 
aeration in the nutrient medium compared to the bacteria grown with aeration in 
deoxycholate citrate agar (Govan, 1975). In case of the PAO1-derivative PDO300, the rate 
of mucoid to non-mucoid conversion was found to be 90 % within 48 hours (Sautter et al., 
2012). The mucoid to non-mucoid conversion has been mapped to mutations in the algT/U 
operon, algO, algW, and mucP (Boucher et al., 1996; Qiu et al., 2007; Reiling et al., 2005; 
Sautter et al., 2012; Schurr et al., 1994). The switch from non-mucoid to a mucoid 
phenotype is associated with a poor prognosis for CF patients (Pillarisetti et al.). The 
alginate over-production enables P. aeruginosa to cause persistent infections in the airways 
of CF lungs that results in decreased lung function, increases the risk of respiratory failure, 
and ultimately the demise of the CF patients. The change from non-mucoid to mucoid 
phenotype is the result of the mutation of anti-sigma factor MucA resulting in the loss of 
regulation of the alternate sigma factor AlgU. The mutation allows AlgU to become free 
to interact with core RNA polymerase and direct transcription of the alginate biosynthetic 
genes located in the algD operon, in addition to its own operon algU-mucA-mucB-mucC-
mucD. The alternate sigma factor AlgU belongs to the extra-cytoplasmic function (ECF) 
family. AlgU (also called AlgT) is 22 kDa protein that shares 66% identity with the E. coli 
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sigma factor RpoE.  In case of AlgT/U the mutation was mapped to codon 18, where a 
GAC in (Alg+) strains was changed to GGC that encodes glycine (De Las Penas et al., 
1997). Another change was at codon 29, where TAC [Tyr] was changed to TGC [Cys]. 
Both of mutation in codon 18 or codon 29 makes AlgT/U unable to direct the transcription 
resulting in a non-mucoid phenotype of P. aeruginosa. 
Strategy to map suppressor of alginate production mutations 
Cosmid-based technique 
A minimum tiling cosmid library that covers 93.7% of the P. aeruginosa genome 
with 334 colonies is commonly used to map mutation in the genome (Huang et al., 2000). 
Localized mutagenesis  
The localized mutagenesis technique is similar to the one used to obtain 
temperature-sensitive mutant Salmonella typhimurium where transducing phage is in vitro 
mutagenized prior to transduction. To find the novel gene involved in acetylation of 
alginate, small fragment of bacterial DNA encoding the alginate biosynthetic operon was 
placed in a cosmid. Lambda lysate was prepared on E. coli HB101 to package these 
cosmids into phage particles. The packaged cosmids were mutagenized in vitro by 
treatment with hydroxylamine. Hydroxylamine is a highly specific mutagen that reacts 
with cytosine and causes the specific replacement of nucleotide G by an A.  Hydroxylamine 
is a highly specific mutagen that reacts with cytosine and causes the specific replacement 
of nucleotide G by an A. Then the mutagenized cosmid is packed in the phage and 
transduced into E. coli. 
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Then the mutagenized cosmid is packed in the phage and transduced into E. coli. Then 
triparental mating is done to transfer the mutagenized cosmid from E. coli to P. aeruginosa 
and finally, P. aeruginosa carrying the mutagenized cosmid is screened for the particular 
phenotype (Franklin and Ohman, 1996). 
Sequencing-based technique 
In whole genome sequencing-based approach purified DNA from the suppressor 
strain can be used for sequencing using high throughput sequencing platform. Several 
sequencing platforms such as Illumina Hiseq200 can be used. 
Purpose of my study 
Our lab isolated nonmucoid revertants termed as a suppressor of alginate 
production strains (sap) derived from the constitutively mucoid (Alg+) PDO300. One of 
the previously uncharacterized sap mutants, sap27 (non- mucoid), was used in the present 
study. Complementation of the sap27 by a cosmid pMO012217 from the P. aeruginosa 
cosmid library restored the mucoid phenotype of sap27 suggesting the at least one the 
genes in the cosmid is required for the mucoid phenotype. Preliminary transposon 
mutagenesis suggests a three-gene operon (lptD-surA-pdxA; PA0595-PA0594-PA0593), is 
involved in alginate overproduction. To map the specific gene responsible for this 
complementation in the cosmid pMO02217, and to understand its role in alginate 
production/regulation, the project has following three aims:  
Specific Aim 1: To map the genes on pMO012217 involved in alginate 
production. The working hypothesis is that one of the 18 open reading frames (ORF) 
present in the cosmid is responsible for restoring the mucoid phenotype in sap27. The 
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preliminary result suggests a three-gene operon (lptD-surA-pdxA), is involved in alginate 
overproduction. The genes were individually expressed in sap27 to identify the gene 
involved in alginate production. In addition, the gene in sap27 was sequenced. 
Subsequently, the role of the gene in alginate production was determined.  
Specific Aim 2: To determine the mechanism of action of LptD. The working 
hypothesis is that LptD bypasses the proteins that are involved in alginate production in 
sap27. To test this, LptD was overexpressed in the strains whose previously known alginate 
related gene was deleted and scored for the revertant mutant to understand the gene 
hierarchy of LptD in RIP cascade. 
Specific Aim 3: To identify the role of PLP in virulence of P. aeruginosa. 
Preliminary data show an exogenous addition of pyridoxal 5’-phosphate (PLP) can affect 
Figure 1.8. Pyocyanin production pathway in P. aeruginosa. Erythose-4-phosphate 
and phosphoenol pyruvate are precursors for synthesis of both vitamin B6 and 
shikimiate. Then shikimate is converted into chorismic acid that eventually converted 
into pyocyanin. Culturing P. aruginosa in a media with vitamin B6 or in presence of 
aromatic amino acid directs the pathway to pyocyanin production. 
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pyocyanin production. To understand the pathway for pyocyanin production we used 
quantitative PCR of the genes shown in purple color (Figure 1.8). 
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Abstract 
The emergence of increased alginate producing mucoid strains is linked to a poor 
prognosis in people with cystic fibrosis. The mucoid phenotype is very unstable outside of 
the CF lung. In this study, a set of nonmucoid revertant strains was used to identify novel 
genes involved in alginate production. Complementation analysis of these mutants using a 
minimal tilling path cosmid library identified a cosmid pMO012217 that restored the 
mucoid phenotype of sap27. The cosmid contains 18 open reading frames. Transposon 
mutagenesis of the cosmid mapped the mutation to LptD (PA0595) encoding a 
Lipopolysaccharide transport protein D (LptD), a protein associated with 
lipopolysaccharide transport to the outer membrane of the bacterium. We established LptD 
is part of three gene operon lptD-surA-pdxA. Our result indicates LptD alone restored the 
mucoid phenotype of sap27. We took the advantage of PAO1, and its isogenic mucA22 
mutant PDO300; and algO, and algW mutant of both of these mutants as well of the 
plasmids harboring algO and algW to identify the pathways that restored the mucoid 
phenotype of the bacterium due to LptD.                                                                                         
Introduction 
Pseudomonas aeruginosa, a Gram-negative, ubiquitous bacterium is pathogenic to 
plants, animals, and humans (Bayes et al., 2016; McAvoy et al., 1989; Rahme et al., 1995). 
The most severe P. aeruginosa infections in humans include endocarditis, malignant otitis 
externa, septicemia, endophthalmitis, eye keratitis, pneumonia, and meningitis (Bodey et 
al., 1983). Annually, there are 51,000 P. aeruginosa infections of which 6,700 are 
multidrug-resistant isolates causing 440 deaths in the USA (2015). The Centers for Disease 
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Control and Prevention has ranked P. aeruginosa as a pathogen of serious threat level 
(CDC, 2015).  
P. aeruginosa is the leading cause of morbidity and mortality in patients with CF 
(2016). Colonization of the lungs of CF patients starts a few years after birth and remains 
for life (Hoiby et al., 1977) An early acute infection transitions to a chronic phase when 
isolated P. aeruginosa colonies exhibit a mucoid phenotype due to constitutive production 
of alginate (Alg+) (Doggett et al., 1971; Hoiby et al., 1977). Though alginate-producing P. 
aeruginosa is primarily associated with CF individuals, occasionally it has been isolated 
from patients with bronchiectasis, urinary tract, and middle-ear infections (McAvoy et al., 
1989). Mucoid P. aeruginosa strains have also been isolated from wastewater systems, and 
the guttural pouch of an equine with chronic mucopurulent nasal discharge (Govan et al., 
1992; Grobe et al., 1995).  
The presence of alginate-producing strains in the lungs of CF patients is associated 
with poor prognosis (Hoiby, 1975; Pedersen et al., 1992). Alginate protects P. aeruginosa 
from phagocytosis, antibiotics, oxygen radicals, and the host immune response (Govan and 
Fyfe, 1978; Hodges and Gordon, 1991; Kulczycki et al., 1978; Mathee et al., 1999; Oliver 
and Weir, 1985; Schwarzmann and Boring, 1971). The importance of alginate in the 
virulence of P. aeruginosa has also been demonstrated in mouse models (Boucher et al., 
1997a; Bragonzi et al., 2006; Pier et al., 2001; Song et al., 2003; Yu et al., 1998). 
Compared to wild-type P. aeruginosa, an alginate-overproducing strain causes aggressive 
polymorphonuclear (PMN) leukocyte infiltration (similar to human infection) and causes 
inefficient pulmonary clearance (Song et al., 2003). A protracted lung infection has the 
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potential to spread to other organs, such as the spleen has observed in the mouse model 
(Song et al., 2003). These properties suggest that alginate is an important virulence factor.  
Exposing the bacteria to stress can induce alginate production. Mucoid conversion 
of P. aeruginosa in vitro can be triggered by growth in high osmolarity media, with limited 
nutrients (like nitrogen, phosphate, and carbon), static culture in acetamide broth, 
continued culture in the presence of antibiotics, Pseudomonas Isolation Agar supplemented 
with ammonium metavanadate, ethanol dehydration and extended exposure to oxygen 
radicals such as hydrogen peroxide (Damron et al., 2011; Devault et al., 1990; Evans and 
Linker, 1973; Govan and Fyfe, 1978; Mathee et al., 1999; Speert et al., 1990; Terry et al., 
1991). Alginate production can also be stimulated by anaerobiosis (Bragonzi et al., 2006; 
Hassett, 1996; Worlitzsch et al., 2002). Though it is difficult to ascertain every factor 
involved, it appears that in CF patients, continuous exposure to antibiotics and PMN-
derived hydrogen peroxide may be the major contributors of mucoid conversion in P. 
aeruginosa (Mathee et al., 1999). 
Alginate production is tightly controlled by a myriad of regulatory factors. AlgR, 
AmrZ (previously called as AlgZ), AlgB, and AlgT/U regulate transcription of the algD 
operon (Baynham and Wozniak, 1996; Goldberg et al., 1993; Kato and Chakrabarty, 1991; 
Leech et al., 2008; Mohr et al., 1992; Worlitzsch et al., 2002; Wozniak and Ohman, 1991). 
The AlgR and AlgB proteins are response regulators of different two-component systems, 
FimS-AlgR, and KinB-AlgB that are essential for high levels of alginate synthesis 
(Goldberg and Dahnke, 1992; Goldberg and Ohman, 1987; Ma et al., 1997a; Whitchurch 
et al., 1996; Wozniak and Ohman, 1991; Yu et al., 1997). However, the conserved 
phosphorylation domains of both AlgB and AlgR are not required for alginate production 
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(Damron et al., 2009; Ma et al., 1998; Worlitzsch et al., 2002). Phosphorylated AlgR is 
not needed for alginate production but plays a role in twitching motility (Whitchurch et al., 
1996). Another protein that increases alginate production is AmrZ, a ribbon-helix-helix 
DNA binding protein (Baynham and Wozniak, 1996). The membrane-associated cyclic-
dimeric-GMP synthesizing protein MucR is also required for the synthesis of alginate in 
P. aeruginosa (Hay et al., 2009).  
The master regulator of alginate synthesis is AlgT/U (σ22), which belongs to the 
family of the extracytoplasmic sigma factors (ECF) and has high homology to SigE (σE) 
found in E. coli, Streptomyces coelicolor, Bacillus subtilis and Salmonella Typhimurium 
(Devries and Ohman, 1994a; Hershberger et al., 1995; Lonetto et al., 1992; Martin et al., 
1993; Worlitzsch et al., 2002; Wozniak and Ohman, 1994). Expression of algT/U is 
autoregulated, and AlgT/U, in turn, regulates expression of the algD, algB, algR, amrZ and 
mucE operons (Baynham and Wozniak, 1996; Devries and Ohman, 1994b; Wozniak and 
Ohman, 1994; Yin et al., 2013). The algT/U gene is a part of the algT/U-mucA-mucB-
mucC-mucD operon that plays an essential role in converting nonmucoid P. aeruginosa 
into its mucoid phenotype (Devries and Ohman, 1994a; Goldberg et al., 1993; Martin et 
al., 1993). MucA is an inner membrane protein, and its N-terminal domain in the cytoplasm 
sequesters AlgT/U and prevents its activity (Mathee et al., 1997; Xie et al., 1996). Most 
mucoid CF isolates acquire mutations in mucA, and 84% of these harbor a common allele 
known as mucA22 that has a deletion of one nucleotide in a stretch of five guanine 
nucleotides located at position 426-430 of the open reading frame (ORF) resulting in 
premature translation termination (Boucher et al., 1997b; Bragonzi et al., 2006; Martin et 
al., 1993). MucA truncation leads to the constitutive production of alginate. In addition, 
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inactivation of mucB and mucD also leads to constitutive alginate production (Boucher et 
al., 1996; Goldberg et al., 1993; Martin et al., 1993; Schurr et al., 1996). 
In P. aeruginosa, MucE accumulates in response to cell wall stress (Step 1, Figure. 
1.7(B)) then the site-1 RIP serine-protease AlgW is activated to clip the C-terminus of 
MucA between amino acids Ala136 - Gly137 in the periplasm (Step 2, Figure. 1.7(B)) 
(Cezairliyan and Sauer, 2009; Qiu et al., 2007). Then, the site-2 zinc-metalloprotease MucP 
cleaves MucA within the inner membrane (Step 3, Fig. 1.7(B)) but the exact cleavage site 
remains to be elucidated (Damron et al., 2011; Wood and Ohman, 2009). The MucA 
fragment tethered to AlgT/U is further processed by a cytoplasmic protease protein 
complex ClpXP with the aid of the SspA protein, finally releasing the sigma factor AlgT/U 
(Qiu et al., 2008a; Yin et al., 2013). The MucA C-terminus that lies on the periplasmic side 
is presumed to bind MucB (Cezairliyan and Sauer, 2009; Mathee et al., 1997). It has been 
shown in vitro that the presence of MucB in the reaction mixture prevents the cleavage of 
MucA by the periplasmic protease AlgW (Cezairliyan and Sauer, 2009). MucD is a 
chaperone/protease that controls periplasmic protein quality and can trigger the 
degradation of MucA upon detection of abnormal protein accumulation (Damron and Yu, 
2011; Wood and Ohman, 2006). In the mucD mutants, an alternate RIP pathway appears 
to be activated in which MucP directly cleaves MucA without pre-cleavage by AlgW 
(Damron and Yu, 2011; Qiu et al., 2007). The role of MucC is currently controversial: 
reportedly being a positive and a negative regulator of alginate production (Boucher et al., 
1997a; Ohman, 1996). AlgO is a serine periplasmic protease that positively affects alginate 
production in P. aeruginosa; however, its precise role in the RIP cascade remains to be 
elucidated (Reiling et al., 2005; Sautter et al., 2012). AlgO, AlgW, and MucD contain PDZ 
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(PSD-95/Discs-large/ZO1) domains that are involved in the protein-protein interaction 
(Ponting, 1997). In the wild-type background, the release of AlgT/U requires the sequential 
degradation of MucA through a process known as regulated intramembrane proteolysis 
(RIP) (Figure. 1.7), a process that is conserved from bacteria to humans (Ruiz et al., 2008; 
Wood and Ohman, 2009).  
Besides mutations in biosynthetic and regulatory genes, alginate production in P. 
aeruginosa can be suppressed by various means that includes increasing the copy number 
of genes such as rpoD, prolonged growth in the presence of sulfate ions or without aeration 
(Min et al., 2014; Ohman and Chakrabarty, 1981; Yin et al., 2013). The reversion 
phenotype has been exploited to study the regulation and to find novel genes associated 
with alginate production (Devries and Ohman, 1994b; Min et al., 2014; Sautter et al., 
2012).  The reversion from mucoid to nonmucoid, when grown without aeration, was 
mainly mapped to mutations in algT/U and algO (Devries and Ohman, 1994a; Sautter et 
al., 2012). In this study, the reversion phenomenon was further exploited to map novel 
genes using a genetically well-defined constitutively mucoid strain, PDO300, with a 
mucA22 allele derived from the prototypic nonmucoid PAO1 strain to isolate nonmucoid 
variants that are termed suppressor of alginate production (sap) mutants (Mathee et al., 
1999; Sautter et al., 2012). One of the previously uncharacterized sap mutants, sap27, was 
used in this study. Complementation and mutational analysis led to the identification of 
lptD (PA0595), encoding an outer membrane protein as responsible for restoring the 
mucoid phenotype. However, sap27 had no mutation in lptD, but in algO. This study will 
explore the role of LptD and AlgO in alginate production. 
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METHODS 
Bacterial strains, plasmids, media and primers 
The E. coli and P. aeruginosa strains and plasmids used are listed in Table 2.1. E. 
coli was grown in Luria-Bertani (LB) medium supplemented with chloramphenicol (Cm, 
10 μg ml−1), gentamicin (Gm, 15 μg ml−1), and kanamycin (Km, 25 μg ml−1) as required. P. 
aeruginosa was grown in LB or LB-PIA (at 1:1 LB agar and Pseudomonas isolation agar 
(PIA)  (Mathee et al., 1997). The LB-PIA media was used to select for trans conjugants. 
Tetracycline (Tc, 100 μg ml−1), and gentamicin (Gm, 100 μg ml−1) were used for P. 
aeruginosa. Cultures were grown at 37°C unless otherwise stated.  
DNA manipulations 
All molecular techniques were performed according to standard protocols 
(Sambrook et al., 1989). DNA sequencing was performed at Genewiz. Inc. (South 
Plainfield, NJ). All primers (Table 2.2) used in the experiments were synthesized and 
supplied by Integrated DNA Technologies (Coralville, IA). 
Triparental mating 
Plasmids and cosmids were conjugated into P. aeruginosa via triparental mating 
using mobilizer plasmids pRK2013, and pRK600 (Figurski and Helinski, 1979; Finan et 
al., 1986). Trans conjugants were then selected for on LB-PIA (1:1) plates containing Tc 
(100 μg ml−1) or Gm (100 μg ml−1). 
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Isolation of sap mutants 
Thirty-four nonmucoid sap mutants were isolated in a previous study, and a subset 
of those was characterized earlier (Sautter et al., 2012).  One of the uncharacterized 
mutants, sap27, is the subject of this study.  
Complementation of sap27 
En masse complementation was performed using the minimal tiling path (MTP) 
library  (PAO1 library that contains 336 clones covering 93.7% of the genome) obtained 
from Paul Phibbs, East Carolina University (Huang et al., 2000). The 334 clones were 
previously pooled into four donor pools, each of which originated from the four-microtiter 
plates (MTP1-MTP96, MTP97-192, MTP193-MTP288, and MTP289-MTP334) used for 
the library’s storage (Sautter et al., 2012). To score for mucoidy, LB:PIA plates with and 
without glycerol were used to reduce false positives. After one-two days of growth at 37°C, 
colonies were restreaked to confirm the mucoid phenotype. The identity of the cosmid was 
confirmed as described previously (Sautter et al., 2012). The ability of the cosmid 
pMO012217 to complement was further confirmed by using the original MTP strain — 
MTP36 (Table 2.1).  
Table 2.1. Bacterial strains and plasmids used in this study 
Strains/plasmids Genotype/description References 
Strains   
E. coli     
DH5α fhuA2 Δ(argF-lacZ)U169 phoA 
glnV44Φ80Δ(lacZ)M15 gyrA96 recA1relA1 endA1 
thi-1 hsdr17  
New 
England 
Biolabs 
MTP36 TcR; pMO012217 (PAO1 fragment 637674–
658948) 
(Huang et 
al., 2000) 
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P. aeruginosa   
 
PAO1 Alg−; Prototypic strain, nonmucoid  (Holloway, 
1955) 
PDO300 Alg+; PAOmucA22, constitutively mucoid  (Mathee et 
al., 1999) 
PKM800 Alg−; mucA22 algO107 (a derivative of PDO300 
(sap22)) 
Previously 
called 
algO96; 
(Sautter et 
al., 2012) 
PKM817 Alg−; mucA22 algO107 (a derivative of PDO300 
(sap27)) 
This study 
PKM832 Alg−; ΔalgO (PAO1 derivative with a clean in-
frame deletion of algO) 
 
PAO∆algO; 
HK403; 
This study 
PKM833 Alg−; mucA22 ΔalgO (PDO300 derivative with a 
clean in-frame deletion of algO) 
PDO∆lagO; 
HK404; 
This study 
PKM834 Alg−; ΔalgW (PAO1 with clean in-frame deletion of 
algW) 
PAOΔalgW; 
HK409; 
This study 
PKM835 Alg−; mucA22 ΔalgW (PDO300 derivative with a 
clean in-frame deletion of algW) 
PDOΔalgW; 
HK410; 
This study 
Plasmids   
pAlgO TcR; derivative of pVS1 with algO pRTS6000; 
(Sautter et 
al., 2012) 
pLAFR3 TcR; Cloning vector  (Staskawicz 
et al., 1987) 
pRK600 CmR; colE1 tra+ rk2 mob+; Helper plasmid for 
conjugation 
(Finan et 
al., 1986) 
pRK2013 KmR; colE1 tra+ rk2 mob+; Hplasmid for 
conjugation 
(Figurski 
and 
Helinski, 
1979) 
pMQ72 GmR; colE1; Expression vector containing 
arabinose promoter  
(Shanks et 
al., 2006) 
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pEXG2 GmR; colE1, oriT mob+ sacB+; P. aeruginosa 
suicide vector with sucrose counterselection 
(Rietsch et 
al., 2005) 
pMQ30 GmR; colE1, oriT sacB+; P. aeruginosa suicide with 
sucrose counter selection 
(Shanks et 
al., 2006) 
pSP50 GmR; colE1; A pMQ72 derivative with a  ~ 5.01-kb 
fragment containing lptD operon downstream of 
PBAD 
pLptD-
operon; This 
study 
pSP51 GmR; colE1; A pMQ72 derivative with a  ~ 2.77-kb 
fragment containing lptD downstream of PBAD 
pLptD; This 
study 
pSP155 GmR; colE1; A pMQ72 derivative with a  ~ 1.29-kb 
fragment containing surA downstream of PBAD 
pSurA; 
This study 
pSP156 GmR; colE1; A pMQ72 derivative with a  ~ 0.98-kb 
fragment containing pdxA ORF downstream of PBAD 
pPdxA;  
This study 
pSP157 GmR; colE1; A pMQ72 derivative with a ~ 4.04-kb 
fragment containing lptD-surA downstream of PBAD 
pLptD-
SurA; This 
study 
pSP158 GmR; colE1; A pMQ72 derivative with a  ~ 2.37-kb 
fragment containing optP downstream of PBAD 
pOptP;  
This study 
pSP160 GmR; colE1; A pMQ72 derivative with a  ~ 0.62-kb 
containing lptE downstream of PBAD 
pLptE;  
This study 
pSP161 GmR; colE1; A pSP157 derivative with lptE ORF 
from pSP160 subcloned downstream of lptD-surA 
creating an operon with lptD-surA-lptE downstream 
of PBAD 
pLptD-
SurA-LptE;  
This study 
pSP162 GmR; colE1; A pMQ72 derivative with a 2.77-kb 
containing lptD fused to six histidine residues at C-
terminus and cloned downstream of PBAD 
pLptD-His6; 
This study 
Mutagenesis of pMO012217  
The sap27 mutant strain with the pMO012217 cosmid has the mucoid phenotype. 
This phenotype in the trans conjugants would be lost if the gene responsible for the 
complementation in the cosmid is disrupted by transposon mutagenesis.  To accomplish 
this, the pMO012217 cosmid was mutagenized in vitro using the EZ::TN transposon 
according to the manufacturer’s protocol. A 200 nanogram aliquot of pMO012217 was 
subjected to the EZ::Tn5 <KAN-2> insertion reaction for six hours (Epicenter 
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Biotechniques, Madison, WI) followed by transformation into E. coli DH5α cells. The 
transformants were cultured on a plate-containing Km (30 μg ml-1). More than 500 
transformants were pooled as the donors for triparental mating with sap27. The trans 
conjugants were screened for the non-mucoid phenotype. Then, the mutagenized cosmid 
was isolated from sap27, and the transposon junction was sequenced using the KAN-2 FP-
1 primer (Table 2.2) to identify the disrupted ORF. 
Table 2.2. Primers used in this study 
Primers Name Sequences (5′ - 3′) 
SP_OptP_(F) ACCCGTTTTTTTGGGCTAGCGAATTCGAGCTCG
GTACCCGGGGAAGGAGATATACATATGAAGCAC
CACTACCGCCT 
SP_OptP_(R) AATCTTCTCTCATCCGCCAAAACAGCAAGCTTG
CATGCCTGCAGTCAGAAGTCGTAGCGCAGCGA 
SP_Seq_OptP1 CTATAATCACGGCAG 
SP_Seq_OptP2 ACAACGTCTACCTGG 
SP_Seq_OptP3 CGCCAAGGTCGAGCG 
SP_Seq_OptP4 CTGATTTAATCTGTA 
SP_Seq_OptP5 CCGCAGGGCACGGGG 
SP_Seq_OptP6 GACCTTCCTGCGCTG 
SP_Seq_OptP7 TGCCCTGCGGACCGC 
SP_Seq_pMQ72_(F) CTAACCAAACCGGTAACCCC 
SP_Seq_pMQ72_(R) AATTGATGCCTGGCAGTTCC 
SP_LptD_Operon_(F) ACCCGTTTTTTTGGGCTAGCGAATTCGAGCTCG
GTACCCGGGGAAGGAGATATACATATGGCAGTG
AAATCCCTCGTG 
SP_LptD_Operon_(R) AATCTTCTCTCATCCGCCAAAACAGCCAAGCTT
GCATGCCTGCAGTCAGCAGCGGCTGGCCGCCATC
TG 
SP_LptD_(F) ggctaggaattcctaggagatataccATGGCAGTGAAATCCCTC
GTGTTTCGAA 
SP_LptD_(R) acgttcatcccgggTTACATAGCTTGATCTTCACGTTGACG 
SP_LptD-SurA_(F) ggctaggaattcctaggagatataccATGGCAGTGAAATCCCTC
GTGTTTCGAA 
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SP_LptD-SurA_(R) acgttcatcccgggTCACTGCTTGATTTCCACGTAGGCCTC 
SP_SurA_(F) ACCCGTTTTTTTGGGCTAGCGAATTCGAGCTCG
GTACCCGGGGAAGGAGATATACATATGAAGATC
AAGCTATGTAAC  
SP_SurA_(R) AATCTTCTCTCATCCGCCAAAACAGCCAAGCTT
GCATGCCTGCAGTCACTGCTTGATTTCCACGTAG
GCCTC 
SP_PdxA_(F) ACCCGTTTTTTTGGGCTAGCGAATTCGAGCTCG
GTACCCGGGGAAGGAGATATACATATGAGCCTG
CGCTTCGCGCTC  
SP_PdxA_(R) 
 
AATCTTCTCTCATCCGCCAAAACAGCCAAGCTT
GCATGCCTGCAGTCAGCAGCGGCTGGCCGCCATC
TG 
SP_JuntSurAPdxA_(R) TTGATCACGCCCTTGTGCA 
SP_LptD_Seq1 AAATCCCGCAGTGCGGACTA 
SP_LptD_Seq2 ACAACGCCGAGTACGTGATCCA 
SP_LptD_Seq3 AAGGCGAGTTCCGCTACCTGA 
SP_LptD_Seq4 GGAATGCAATTCACCTATGGCA 
SP_LptD_Seq5 CCATGTACTTGTACGTTCCAT 
SP_LptD_Seq6 GGTAGCGCCATCTTCCACTA 
SP_LptD_Seq7 GTAGGCAACAAGACGGAAATG  
SP_LptD_Seq8 CGGTGGCAGGTTGGCATT 
SP_LptD_Seq9 TAGTCCGCACTGGGGGATTT 
SP_LptD_seq10 GGGAGCAATCCCAG 
SP_SurA_Seq1 GTGCACCAGACGCTG 
SP_SurA_Seq2 GGCCAATATCCTGATC 
SP_SurA_Seq3 CTGCTCAAGCCCAGC 
SP_SurA_Seq4 CCGTCGCGGGTGAGGG 
SP_SurA_Seq5 GCCGAACTGCGAGCGG 
SP_PdxA_Seq1 TTCCGGCCATACCGAA 
SP_PdxA_Seq2 CAGACCAGGATGCGCGGAT 
Cos-1 CGCCCTCTGGTAAGGTTG 
pLA2 CCTGTCTCTTGATCAAGATC 
KAN-2 FP-1 ACCTACAACAAAGCTCTCATGAACC 
HK_AlgW_DR CCAGGCAAATTCTGTTTTATCAGACCGCTTCTGCGT
TCTGATTGGATGAAAGGTTCCGCA 
HK_AlgW_DF CCCCAAGGATTTTCCCGATGCTAGCTAACTAGTCC
CCGTCATTGAAAACGGC 
 52 
 
HK_AlgW_UR GCCGTTTTCAATGACGGGGACTAGTTAGCTAGCAT
CGGGAAATCCTTGGGG 
HK_AlgW_UF GGAATTGTGAGCGGATAACAATTTCACACAGGAA
ACAGCTGTCTGCTCGGAAACCTCGCC 
HK_AlgW_P1_FW_Se
q 
TAATGGACGGCTTCCCCCTA 
HK_AlgW_P2_RE_Seq CAGGGAGTCATCGTCCGCCA 
HK_AlgW_P3_FW_Ex
t 
AGCGCCTGTACCCCGTAGC 
HK_AlgW_P3_RE_Ext GCTGTTTCCGGACGTGACCTAC 
SP_AlgO _(F) ATTAATAAGCTTGCTGCCTCCATAGTGGG 
SP_AlgO_(R) AATTATAAGCTTTTATGACGCTCCCGCTGAACT 
CC_AlgO_P1_(F) AAGCTTAGCAACTCCAGGTTCAACCCGG 
CC_AlgO_P1_(R) GCTAGCGCTGATTCGACTGATCGCGGAGT 
CC_AlgO_P2 _(F) GCTAGCGTTCAGCGGGAGCGTCATAAA 
CC_AlgO_P2_(R) GGATCCCGAGGTGCGAACGTCGACCGCG 
CC_AlgO_Seq1 GGCGCTGCCGACGGAGAC 
CC_AlgO_Seq2 GCAACAGGTTCGACGACT 
CC_AlgO_Seq3 CGGACAACGCGGAAAACT 
CC_AlgO_Seq4 CTACAAGCTCGGCGTGAT 
CC_AlgO_Seq5 ACCGTGCAGACCATCCAGC 
CC_AlgO_Seq6 CCAGTTGGCCATGGAGAACG 
CC_AlgO_Seq7 CATCGACCAGGGCCCGACCG 
CC_AlgO_Seq8 GTGTCCCAGGGCATCGAGTCG 
CC_AlgO_Seq9 TGGCGATGACCTGCTCGCGG 
CC_AlgO_Seq10 GTCCAGGTAGAAGGCGGGCA 
CC_AlgO_Seq11 GAGCCGACCTTTCAGGCGG 
SP_LptE_(F) ggctagcccgggtaggagatataccATGAAACGTATCCTGACCA
GCGCCGCGC 
SP_LptE_(R) cagccaagcttTCACGGGGTGGGGAACTCGATCGG 
SP_LptD-HindII_6xHis 
(R) 
GCAaagcttTTAATGATGATGATGATGATGCATAGC
TTGATCTTCACGTTGACG 
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Alginate assay 
In brief, cells from a single plate were harvested after growth in LB for 36 hr and 
resuspended in 5 ml PBS (pH 7.4) and the OD600 was determined. Then, the cell 
suspension was centrifuged at 12,000 X g for 30 minutes. The supernatant was collected, 
and the alginate was precipitated using 5 ml of 2% (w/v) cetylpyridinium chloride. The 
mixture was centrifuged at 12,000 X g for 10 minutes and the pellet was resuspended in 5 
ml of 1 M NaCl and 5 ml of cold (-20 °C) isopropanol. The suspension was again 
centrifuged at 12,000 X g for 10 minutes and the pellet was dried at 37 °C for 30 minutes 
to evaporate any residual isopropanol. Finally, the pellet was resuspended in 5 ml of 0.9% 
(w/v) NaCl. To determine the alginate concentration, a set of standards was made with 
sodium alginate (Sigma-Aldrich, St. Louis, MO).  The amount of alginate was determined 
using a borate/carbazole method. A 70-μl-alginate sample was mixed with 600 l of ice-
cold borate solution then immediately placed on ice and was followed by the addition of 
20 μl of 0.1% carbazole and mixed briefly. Then the mixture was heated for 30 minutes at 
55 °C, and the absorbance was measured at 530 nm. The absorbance was compared with 
standards to determine the alginate concentration which was expressed in mg per ml 
supernatant and normalized to the bacterial OD600 = 0.41 (Qiu et al., 2007). All the alginate 
assays were performed in triplicate.  
Construction of plasmids containing the ORF lptD-operon, surA, pdxA, and optP  
The ORFs surA, pdxA and optP were amplified from the genomic DNA of PAO1 
using standard procedures (Sambrook et al., 1989). The primer pairs 
SP_LptD_Operon_(F), and SP_LptD_Operon_(R), SP_SurA_(F) and SP_SurA_(R), 
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SP_PdxA_(F)-SP_PdxA_(R), and SP_OptP_(F)-SP_OptP_(R), (Table 2.2) were used to 
amplify the lptD-operon (5.01 kb), surA (1.29 kb), pdxA (0.98 kb), and optP (2.373 kb), 
respectively. The forward primers used contained a ribosome-binding sequence upstream 
of the start codon of the respective ORFs as well as 45-bp tails (shown in bold, Table 2.2) 
that target recombination downstream of the PBAD promoter on pMQ72 that has pRO1600 
and colE1 origins of replication (Shanks et al., 2006). The respective reverse primers also 
have 44-bp tails (shown in bold, Table 2.2) that target recombination upstream of T1T2 
transcriptional terminators present in the vector (Shanks et al., 2006). The vector pMQ72 
was digested with restriction enzyme SmaI. Then the digested vector pMQ72 along with 
PCR product were co-transformed into overnight cultures of Saccharomyces cerevisiae 
(Shanks et al., 2006). The transformed cells were individually tested for the desired 
construct by colony PCR using the primer pair SP_Seq_pMQ72_(F)—
SP_Seq_pMQ72_(R) for the presence of an insert (Shanks et al., 2006; Shanks et al., 
2009). E. coli DH5 was then transformed with the recombinant pMQ72 plasmids 
containing their respective ORFs and screened for Gm resistance. The amplified ORFs 
from the recombinant plasmids were sequenced to ensure fidelity (Table 2.2). The plasmids 
with PBAD driving the expression of lptD-operon, surA, pdxA, and optP are pSP50, pSP155, 
pSP156, and pSP158, respectively (Table 2.1). These plasmids henceforth will be referred 
to as pLptD-operon, pSurA, pPdxA, and pOptP, respectively.  
Construction of plasmids containing the lptD, surA and lptE 
The ORFs, lptD (2.77 kb), lptD-surA (4.048 kb), and lptE (0.62 kb), were amplified 
from PAO1 genomic DNA using the primer pairs SP_LptD_(F)—SP_LptD_(R), 
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SP_LptD-SurA_(F)—SP_LptD-SurA_(R), and SP_LptE_(F)—SP_LptE_(R), 
respectively (Table 2.2). The amplified product lptD and lptD-surA were digested with the 
enzymes EcoRI and XmaI then ligated downstream of PBAD in pMQ72 (Shanks et al., 2006) 
cut with same restriction enzymes. Then, the resulting plasmids harboring lptD and lptD-
surA genes were named as pSP51 and pSP157, respectively.  
The PCR-amplified product of lptE was restriction digested by enzymes XmaI and 
Hindlll then ligated downstream of PBAD in pMQ72 digested with same restriction enzymes. 
Then the lptE harboring plasmid was named as pSP160. The lptE fragment of pSP160 was 
subcloned into plasmid pSP157 downstream of lptD-surA using restriction enzymes XmaI 
and HindIII to create pSP161. The plasmid pSP161 contains lptD-surA-lptE under the 
control of PBAD.  
All the constructs were sequenced to ensure fidelity using the appropriate primers 
shown in Table 2.2. The constructs, pSP51, pSP157, pSP160 and pSP161, henceforth will 
be referred to as pLptD, pLptD-SurA, pLptE and pLptD-SurA-LptE, respectively.  
His-tagging of LptD 
A 2.77-kb fragment with lptD was amplified from PAO1 genomic DNA using the 
primer pairs SP_LptD (F) and SP_LptD-6xHis (R) (Table 2.2). The latter primer has six 
histidine codons added in frame to the 3’ end of the coding sequence of lptD. The amplified 
product with lptD-His6 was then ligated downstream of PBAD in pMQ72 to construct 
pSP162 (pLptD-His6). The cloned fragment was sequenced for fidelity. The plasmid 
pLptD-His6 was introduced into the sap27 strain by standard electroporation (Choi et al., 
2006). 
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Western blotting 
Cells were grown to an OD600 of 0.4 and induced with 2 % arabinose for 2 hours at 
25 °C. Then the cells were harvested by centrifugation at the speed of 5,000 rpm at 4°C for 
10 minutes. The pellets were resuspended in 10 ml lysis buffer (20 mM Tris [pH 7.5], 0.1 
M NaCl, 1 mM EDTA, 1X Roche complete protease inhibitor cocktail, lysozyme [0.5 
mg/ml]). After lysis by sonication (15 cycles of 10-s pulse on and 30-s pulse off; amplitude, 
40%), the cell lysates were centrifuged 5,000 rpm for 10 minutes at 4 °C. Two ml of the 
cell lysate from each sample was saved as the total cell fraction, and remaining were further 
fractioned by ultracentrifugation at 36,000 rpm (SW 41 Ti rotor) for one hour at 4°C. The 
supernatants were saved as soluble (cytoplasmic and periplasmic) fraction whereas pellets 
were resuspended with 1 ml of membrane buffer (20 mM Tris-Cl [pH7.5], 0.2 % Sodium 
lauroyl sarcosinate [Sarkosyal; Fluka], 0.1 % Sodium dodecyl sulfate [SDS]). One hundred 
ml of the whole cell, periplasmic/cytoplasmic and membrane fractions were aliquoted and 
stored at -80°C. The concentration of protein was determined by the bicinchoninic acid 
method (Smith et al., 1985). Ten micrograms of total protein were separated on a 12% 
SDS-polyacrylamide gel. The presence of LptD and σ70 (loading control) was detected 
using anti-His6 (Thermo Scientific, Rockford, IL) and anti-σ70 (Neoclone Biotechnologies 
International, Madison, WI) antibodies. The fluorescent secondary antibody (Anti-mouse 
IgG (H+L) (DyLight™ 680 Conjugate) was purchased from Cell Signaling Technology, 
Inc (Danvers, MA). The fluorescence was detected using Odyssey CLX near Infrared 
Imaging System (LI-COR Biosciences, Lincoln, NE). 
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Construction of ∆algO and ∆algW strains 
An in-frame deletion of algO was constructed using overlap extension PCR and 
homologous recombination as previously described (Horton et al., 1990). The upstream 
and downstream flanking regions of algO using the primer pairs CC_AlgO_P1_(F)—
CC_AlgO_P1_(R) and CC_AlgO_P2_(F)—CC_AlgO_P2_(R), respectively were 
amplified and fused to construct the deletion (Table 2.2). The PCR products were then 
ligated through another round of PCR and cloned into the suicide vector pEXG2 (Rietsch 
et al., 2005). The recombinant plasmid was introduced into PAO1 and PDO300, where the 
deletion replaced the wild-type algO on the chromosome via homologous recombination 
using a two-step process, involving screening by Gm sensitivity followed by sucrose 
resistance. PCR amplification of the region spanning the deletion and sequencing 
confirmed the absence of algO. These deletion mutants were called PAO∆algO and 
PDO∆algO. 
A gene-splicing method using the yeast system was used to generate a precise in-
frame deletion of algW in P. aeruginosa (Shanks et al., 2006). Upstream (P1) and 
downstream (P2) flanking regions of algW were amplified from PAO1 genomic DNA by 
PCR using the primer pairs HK_AlgW_UF—HK_AlgW_UR and HK_AlgW_DF—
HK_AlgW_DR (Table 2).  The primers HK_AlgW_UF and HK_AlgW_DR had regions 
of homology to target recombination of P1 and P2 with pMQ30 vector (Shanks et al., 
2006). The primer pairs also had complementary sequences at the 3′ end to facilitate joining 
to create the P3 fragment, as well as stop codons (5′-CTAGTTAGCTAG-3′) to prevent 
translational read through.  The pMQ30 vector has double selection markers URA3 for 
yeast and GmR for E. coli (Shanks et al., 2006). Yeast cells were transformed with the P1, 
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P2 and BamHl-digested linearized pMQ30 using standard protocols and colonies were 
selected on sucrose-uracil plates. The yeast colonies were checked for the presence of the 
P3 construct for algW deletions by amplifications using primer pairs HK_AlgW_UF—
HK_AlgW_DR. Yeast DNA was isolated from the positive colonies as previously 
described (Shanks et al., 2009). E. coli DH5 was transformed with the recombinant 
pMQ30 plasmids containing P3 and screened for Gm resistance. The amplified P3 from 
the recombinant plasmids were sequenced to ensure fidelity. The constructs were then 
conjugated into PAO1 using triparental mating and screened for single and double 
crossovers using counter selection with sucrose and Gm, as previously described (Shanks 
et al., 2006; Shanks et al., 2009). The presence of the gene deletion in all the mutants was 
confirmed using standard molecular methods. The strain is henceforth referred to as 
PAO∆algW. Using similar strategies ∆algW in mucoid PDO300 was constructed and 
named PDO∆algW. 
RNA isolation and cDNA synthesis 
RNA was isolated from P. aeruginosa wild-type PAO1 as described previously 
(Balasubramanian et al., 2014). Briefly, 10-ml overnight cultures grown in LB broth at 
37°C were washed with 0.85% saline solution to remove spent media. Then the cells were 
sub-cultured in 15 ml by inoculating the culture in LB media at an OD600 of 0.01 at 37°C 
at 200 rpm. Subsequently, the cells were harvested when the culture reached an OD600 of 
0.5-0.6.  The RNA was stabilized by addition of phenol-ethanol mixture as described 
previously (Brencic et al., 2009). Stabilized RNA was then isolated using RNeasy Mini 
Kit (Qiagen Inc, Germantown, MD, USA) as per the manufacturer’s protocol. Residual 
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genomic DNA contamination was removed using RQ1 RNase-free DNase (Promega, 
Madison, WI, USA) and RNA was repurified using RNeasy Mini Kit (Qiagen Inc, 
Germantown, MD, USA) The quality of purified RNA was assessed on a denaturing 
agarose gel (NorthernMax Gly, Ambion, Life Technologies, Carlsbad, CA) and quantified 
at OD260 (BioTEK®, Synergy™ HT, Winooski, VT, USA). cDNA was then synthesized by 
annealing NS5 random primers to total purified RNA, and subsequent extension was 
carried out using SuperScript III reverse transcriptase (Invitrogen™, Life Technologies, 
Carlsbad, CA, USA). 
Results 
Identification of the sap27 complementing cosmid 
The sap27 mutant is a nonmucoid revertant isolated by growing mucoid PDO300 
without aeration (Sautter et al., 2012). The mucoid phenotype in sap27 was restored via en 
masse complementation with the PAO1 minimum tiling path (MTP) genomic cosmid 
library (Huang et al., 2000). The complementing cosmid was extracted and the junction 
where the P. aeruginosa genome fragment is integrated was sequenced to identify the P. 
aeruginosa genes contained in pMO012217 (PAO1 coordinates:  637674 to 658948; 
Figure 2.1) (Huang et al., 2000). To ensure that was pMO012217 was the complementing 
cosmid, sap27 was re-transformed by conjugation with E. coli containing the original 
cosmid clone pMO012217 from the MTP library (MTP36) (Figure 2.3(a)). As negative 
controls, PAO1 and sap27 were transformed with vector pLAFR3. As expected, PAO1 
with the vector remained nonmucoid. The positive controls, the Alg+ parent PDO300 with 
the cosmid and plasmid vectors, remained mucoid when transformed individually. The 
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cosmid pMO012217 restored the mucoid phenotype in sap27 (Figure 2.3(a)). The 
pMO012217 cosmid contained 18 ORFs (Figure 2.1) and did not harbor any known 
alginate genes indicating that a novel ORF was involved in the restoration of alginate 
production. 
Mapping the gene in the complementing cosmid pMO012217 using transposon (Tn) 
mutagenesis 
Figure 2.1. Genetic map of cosmid pMO012217 and lptD-operon. The cosmid was identified 
in the en masse complementation of sap27 with the MTP library, which restored the mucoid 
phenotype. The cosmid contains 18 ORF. The figure of the cosmid was retrieved from 
pseudomonas.com and reversed to make it easier for observation because the lptD operon lies 
in negative strand of the chromosome of P. aeruginosa. Through sequencing, we identified the 
transposon was inserted at the end of lptD, which is marked by an orange arrow.  The in silico 
sequence analysis shows that the 3’ of the lptD overlaps with 5’ end of surA, which is shown 
by dotted line [start codon [GTG] of surA begins before stop codon [TAA] of lptD] and stop 
codon of surA [TGA] and start codon [GTG] of pdxA overlaps [GTGA] also shown by dotted 
line that originate from intersection of surA and pdxA. The operon was cloned into an 
expression vector pMQ72 and named as pLptD-operon. Plasmids pLptD-operon, pLptD, 
pSurA, and pPdxA are pMQ72-derived plasmids with lptD-operon, lptD, surA, and pdxA 
insertions, respectively. The plasmids were constructed as described in the materials and 
methods. The red arrow shows the transposon insertion site in lptD gene and the genomic 
position. 
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The rationale for the Tn mutagenesis is that the loss of mucoidy in the trans conjugants 
would be due to the disruption of the complementing ORF present in the cosmid.  
To identify the particular ORF responsible for the mucoid conversion, pMO012217 was 
mutagenized in vitro using the EZ::TN transposon (Epicenter Biotechniques, Madison, WI). 
The transposon mutant library was introduced into sap27 and screened for the loss of the 
mucoid phenotype in the trans conjugants. Sequencing of the Tn junction in the constructs 
that failed to restore the mucoid phenotype using the cos-1 primer (Table 2.2) revealed the 
insertion to be at the 3′ end of lptD (PA0595) at position 653,902 of P. aeruginosa PAO1 
genome (Figure 2.1). This insertion disrupts the alanine codon at the position 876 of LptD, 
truncating the protein.  
Analysis of the lptD locus 
Analysis of the locus suggests that lptD might be a part of the three-gene operon 
(Winsor et al., 2016). Thus, the Tn insertion could have a polar effect on the downstream 
genes, namely surA and pdxA. In E. coli, it has been shown that SurA is an essential protein 
for survival in starvation and a major chaperone protein for all outer membrane protein. 
In E. coli, PdxA is a NAD-dependent dehydrogenase and is involved in the vitamin B6 
biosynthetic pathway (Banks and Cane, 2004; Laber et al., 1999). To verify if lptD-surA 
pdxA forms an operon in P. aeruginosa, total RNA was isolated from PAO1 in late log-
phase, and non-specific primers were used to synthesize cDNA for RT-PCR. The presence 
of cDNA across the pair of ORFs lptD-surA and surA-pdxA would suggest that these genes 
form an operon. The expected PCR products of sizes 1000 bp (Lanes 2, 3 and 5) and 900 
bp (Lanes 8, 9 and 11) for lptD-surA and surA-pdxA, respectively, were observed (Figure 
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2.2). As expected, there was no product in negative controls when amplification was done 
without the DNA polymerase (Lanes 7 and 13); or using RNA prepared after DNAse I 
treatment (Lanes 4 and 10) or without reverse transcriptase (Lanes 6 and 12). 
The presence of expected PCR products in the cDNA (Lanes 5 and 11) confirms 
the existence of mRNA spanning the junctions. These data suggest lptD, surA and pdxA 
form an operon. Since the Tn is inserted at the 3′ end of the first gene, lptD, at 653,902 in  
the three-gene operon, it is possible that all three genes may be involved in alginate 
production (Figure 2.2). Thus, the three ORFs in the lptD-operon alone or combination 
might be responsible for restoring the mucoid phenotype in sap27. To determine the ORF 
Figure 2.2. Verification of lptD is part of a three-gene operon. The PCR 
amplification of the junctions between the genes, lptD-surA and, surA-pdxA with 
specific primer pairs shown in Table 2. The amplified product was run in 1% agarose 
gel. Lane 1, 1 Kb Ladder [M] as a marker; Lanes 2-7 and Lanes 8-13 is the PCR 
products of the junction between lptD-surA and surA-pdxA, respectively. Lanes 2  & 
8, PCR products from genomic DNA [G] used as positive control; Lanes 3,4,9, and 10, 
PCR products before treatment and after treatments (aT) of DNA polymerase; Lanes 5 
& 11, PCR products from cDNA [cD]; Lanes 6 & 12, PCR amplification without the 
reverse transcriptase [-RT] used as negative control; Lanes 7 & 13, PCR amplification 
in the absence of DNA polymerase [-P] used as negative control. 
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responsible, lptD, surA, and pdxA were individually cloned downstream of the PBAD 
promoter and the plasmids were named pLptD, pSurA, and pPdxA, respectively (Table 
2.1). In addition, the entire operon was also subcloned into the same vector (pMQ72). All 
Figure 2.3. Identification and mapping of the gene responsible for restoring 
mucoid phenotype. Identification of genes responsible for restoring the mucoid 
phenotype. (a) The cosmid pMO012217 introduced into sap27 restoring the mucoid 
phenotype. PAO1 and PDO300 were used as negative and positive controls, 
respectively. The plasmid pLAFR3 was used as a control vector. (b) The plasmids 
pLptD and pLptD-operon which harbor lptD and lptD-surA-pdxA were separately 
introduced into sap27 restoring the mucoid phenotype. (c) The plasmids, pMucE and 
pLptD were introduced into PAO1 and sap27 inducing a mucoid phenotype. (d) The 
plasmids, pSurA, pPdxA and pAlgO were introduced into sap27. Mucoid phenotype 
was restored only when sap27(pAlgO) was induced with arabinose. The strains were 
plated on LB containing 2% arabinose (Ara) where indicated and incubated at 37°C for 
36 hours.  
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the constructs were introduced into sap27 and PDO300. The vector (pMQ72) was also 
introduced into sap27 and PDO300 as negative controls. The plasmid harboring mucE 
(pMucE) that is known to induce alginate production was introduced into sap27 and PAO1 
as positive controls (Figure 2.3(c))(Qiu et al., 2007). After 36 hr, the mucoid phenotype in 
sap27 was restored by the pLptD-operon and pLptD in the presence of arabinose (2%) 
(Figure 2.3(b)) but not by pSurA and pPdxA (Fig. 2.3(d)). As expected, the amount of 
alginate produced by sap27 in the presence of lptD and lptD-operon was comparable to 
PDO300 (Figure. 2.4). These findings suggest that lptD alone is sufficient to restore the 
mucoid phenotype in sap27.  
Co-expression of lptD, surA, and lptE in sap27 
The 20 kDa proper folding of LptD in the outer membrane (Chimalakonda et al., 
2011; Chng et al., 2010; Grabowicz et al., 2013). In addition, LptD folding also requires 
the chaperone protein SurA (Vertommen et al., 2009).One could argue that alginate 
production in sap27 is due to stress induced by the accumulation of misfolded LptD as a 
result of increased expression of lptD alone without surA and/or lptE. To rule out the 
potential for LptD misfolding, plasmids with lptD-surA (pLptD-SurA), and lptD-surA-lptE 
(pLptD-SurA-LptE) under the control of PBAD were constructed (Table 2.1). These 
constructs were introduced individually into sap27 and the genes were induced with 
arabinose. Alginate production was restored in sap27 in the presence of both of the 
plasmids individually (Figure 2.4). This suggests that the mucoid conversion of sap27 upon 
lptD overexpression is not due to misfolding of LptD, instead, it is the function of 
increasing the copy number of lptD. 
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Figure 2.4. Alginate levels in the presence of increased expression of lptD. Plasmids 
containing the lptD, lptD-surA, lptD-surA-lptE, optP, oprP, and algO were introduced 
separately into sap27, and strains with clean in-frame deletion of algO [PAOΔalgO and 
PDOΔalgO] and algW [PAOΔalgW and PDOΔalgW]. Cells were grown for 36 hours on 
LB plates supplemented with gentamycin [100 μg/ml for selection and 2% arabinose as 
an inducer. The alginate level was quantified and normalized to an OD600 = 0.41 as 
described in materials and methods. The strains sap27 and PDO300 with vectors were 
used as the negative and the positive control, respectively. The level of significance [p – 
value] is less than 0.05 for each set of experiment. The experiments were done in 
triplicates. 
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The latter would then imply that the concentration of LptD will be higher in sap27 
if the expression of lptD is induced. We confirmed this by His-tagging LptD and Western-
blotting using anti-His6 antibody (Figure 2.5). In addition, we also demonstrate that the 
LptD is only found in the insoluble fraction suggesting membrane localization (Figure 2.5). 
 
 
Expression of optP encoding a large OMP in sap27 
To determine if the mucoid restoration of sap27 is exclusive to lptD, optP 
(PAO192) was expressed under the PBAD promoter in sap27. The protein OptP was chosen 
Figure 2.5. Cellular localization of LptD. Equal amounts of total proteins 
were loaded per well. His-tagged LptD was introduced into sap27 as described 
in materials and methods. Whole cell fractions were extracted from cells that 
were uninduced (-) or induced (+) with 2% arabinose for 3 hours at 25˚C. The 
induced whole cell extract was further separated into soluble and membrane 
fraction. The presence of LptD was shown using anti-His6 antibody. Sigma 70 
was used as the loading controls. The whole cell and membrane fractions were 
probed with unconjugated purified anti-E. coli RNA sigma 70 antibodies. The 
soluble fraction was probed with conjugated Direct-Blot™ HRP anti-E. coli 
RNA sigma 70 antibody, thus the ladder that was run parallel was superimposed 
in this image. 
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as it is predicted to be a large outer membrane protein (790 aa) comparable in size to the 
924-aa LptD (Winsor et al., 2016). Overexpression of optP did not turn the sap27 strain 
into the mucoid phenotype and consequently, no alginate was detected (Figure 2.4), 
suggesting that it is not a general function of large OMPs. This suggests that LptD might 
have potentially a specific role for alginate production in sap27. 
Mapping of the mutation in sap27 
The above finding suggested that sap27 harbors a mutation in lptD. To rule out any 
promoter mutation that may influence lptD expression, the entire operon including the 
promoter region was sequenced in sap27 and no mutation was found. This suggested that 
the increased expression of lptD must be bypassing some other mutation. Our preliminary 
studies showed that the mucoid phenotype in sap22 with a mutation in algO (PA3257) can 
be rescued by another cosmid (Reiling et al., 2005; Sautter et al., 2012). This led to our 
hypothesis that sap27 may harbor a mutation in algO (PA3257). The introduction of a 
Figure 2.6. Mapping the algo mutation in sap27. The codon numbers of the wild-
type algO are shown on top. Sequencing of algO from sap27 revealed an insertion of 
a nucleotide thymine (T) (shown in red) causing a frame-shift at codon 107 leading to 
premature translational termination of AlgO at codon 320 resulting in a truncated 
protein. The amino acid sequences from codon 107 to 319 share no similarity to any 
other P. aeruginosa proteins. 
 
Amino	acid 	106  107  108       318  319  320  321       
PAO1 	 	GCC  GAG  TTC  . .  CTG  GAT  GAA  .
Ala  Glu  Phe  . .  Leu  Asp  Glu  .
sap27 	 	GCC  GAT  GTT  . .  CCT  GGA  TGA
Ala  Asp  Val  . .  Pro  Gly  *
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plasmid carrying algO (pAlgO) into sap27 rescued the mucoid phenotype (Figure 2.3(d) 
and Figure 2.4). Ideally, the cosmid containing algO should have complemented sap27 in 
the original en masse screening. However, it was missed in-part due to the subjective nature 
of the procedure. The sequence analysis of algO, encoding a 709-amino acid long protein 
in sap27 genome, revealed an insertion of a single nucleotide, thymine (T), at position 
3,643,250 on the genome (Figure 2.6). This insertion results in a frame-shift mutation 
leading to premature termination of algO at codon 320 (Fig. 2.6), which is converted from 
glutamic acid to UGA, an opal stop codon. The truncated protein has an identity to AlgO 
at the first 106 amino acids of the N-terminus and the remaining 213 amino acids share no 
similarity to any other P. aeruginosa proteins. In fact, the same mutation was identified in 
sap22 (Reiling et al., 2005; Sautter et al., 2012).  However, the codon number was stated 
differently as the start codon for algO is off by 11 codons that were recently corrected on 
pseudomonas.com (Winsor et al., 2016).  
To ensure the phenotype seen in sap27 is not strain-specific and can be reproduced 
in sap22, the plasmid pLptD was introduced in the latter rescuing the mucoid phenotype 
(Figure 2.3(c)). To further confirm that lptD in trans can overcome the algO mutation, a 
clean in-frame deletion of algO was constructed in PAO1 and PDO300 and the strains were 
named as PAO∆algO (Alg-) and PDO∆algO (Alg-), respectively. The plasmid pLptD-
SurA-LptE was introduced in these strains and induced with arabinose. The increase in 
lptD copy number (expected to be between 1-7 copies) (Jahn et al., 2016). leading to higher 
protein levels in PAO1 and PAO∆algO results in the strains turning mucoid with 
significant production of alginate ((Figure 2.3(c), Figure 2.4). Thus, the LptD-dependent 
alginate-production does not require algO. The induction of lptD in PDO∆algO (Alg-) 
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failed to rescue the alginate phenotype (Figure 2.4). However, the alginate phenotype can 
be rescued by lptD in the sap27 mutant strain (Figure 2.4). Both of these strains express 
truncated MucA (MucA22). The difference between PDO∆algO and sap27 (PDOalgO107) 
is that one has no AlgO whereas the latter expresses a truncated AlgO. This suggests that 
LptD-dependent alginate production in sap27 requires the truncated AlgO. One cannot rule 
out the possibility that the truncated AlgO in sap27 might be contributing to the observed 
phenotype. 
Increased expression of lptD-surA-lptE in ∆algW mutant of PAO1 and PDO300 
To determine if LptD-dependent induction of alginate production has a role in the 
RIP cascade, attempts were made to construct deletion mutants of algW and mucP. 
Repeated efforts to make mucP deletion mutants failed. However, PAO1 and PDO300 
derivatives with clean in-frame algW deletions were constructed and are referred to as 
PAO∆algW and PDO∆algW, respectively. As expected, the loss of algW resulted in the 
loss of alginate production in PDO300 (Figure 2.4). Multiple efforts to complement 
PDO∆algW with algW also failed. The plasmids pLptD and the pLptD-SurA-LptE were 
introduced into PAO∆algW and PDO∆algW. The mucoid phenotype of PDO∆algW was 
rescued by increasing the copy number of lptD (Figure 2.4). Inducing the expression of 
lptD in PAO∆algW did not result in alginate production (Figure 2.4). This suggests that the 
LptD-dependent alginate production in PAO1 requires AlgW. Thus, in a mucA22 
background, LptD can bypass AlgW. 
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Discussion 
The emergence of alginate-producing strains of P. aeruginosa in patients with CF 
is an indication of chronic infection that signals a deterioration of lung function and 
ultimately pulmonary failure. The importance of alginate in CF patients was corroborated 
in the early 1970s. However, the genetic determinant responsible for the conversion was 
mapped to a single locus in the 1980s, and the genes responsible were identified in the 
1990s. Almost 35 years later, with the identification of over 30 alginate genes, a solution 
to prevent mucoid conversion continues to elude us. This study was undertaken to identify 
novel genes by mapping second site-suppressor mutations of alginate production. The gain-
of-phenotype in a non-mucoid sap27 was mapped to lptD (PA0595) encoding an outer 
membrane protein. To date, all the genes involved in the regulation of alginate production 
encode for products that reside in the periplasm, the inner membrane, and the cytoplasm. 
This report demonstrates the potential role of a P. aeruginosa OMP, LptD (PA0595), in 
alginate production. 
LptD transports lipopolysaccharide to the outer leaflet of the outer membrane and 
is an essential OMP in E. coli and P. aeruginosa but not in Neisseria meningitidis (Bos et 
al., 2004; Braun and Silhavy, 2002; Werneburg et al., 2012). In E. coli, LptD is a member 
of the σE regulon with multiple designations: LptD, OstA, and Imp owing to its different 
roles (Abe et al., 2003; Aono et al., 1994; Braun and Silhavy, 2002; Dartigalongue et al., 
2001; Sampson et al., 1989). Actually, LptD designation comes from LipoPolysaccharide 
Transport Protein because of its involvement in outer membrane biogenesis (Braun and 
Silhavy, 2002; Sperandeo et al., 2009), the OstA from organic solvent tolerance A because 
of its importance in the growth of E. coli K12 in xylene and n-hexane (Abe et al., 2003; 
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Aono et al., 1994); and finally, Imp for increased membrane permeability that contributes 
to resistance to antibiotics, detergents and dyes (Charlson et al., 2006; Sampson et al., 
1989). P. aeruginosa LptD is also involved in LPS transport and controlling membrane 
permeability and confers resistance to antibiotics such as rifampin, ciprofloxacin, 
tetracycline, novobiocin, azithromycin and imipenem (Balibar and Grabowicz, 2016; 
Werneburg et al., 2012). Similar to E. coli, P. aeruginosa LptD is involved in LPS 
palmitoylation (Balibar and Grabowicz, 2016; Ruiz et al., 2008; Wu et al., 2006). It is not 
uncommon to find proteins with multiple roles in bacterial physiology, for an example, 
AlgC is involved in LPS, Pel, Psl, alginate, and rhamnolipid production (Ma et al., 2012; 
Olvera et al., 1999; Zielinski et al., 1991). 
Outer membrane protein LptD regulates alginate production 
One can argue that increasing expression will lead to misfolding of LptD that may 
cause alginate production in sap27, since it requires LptE and the SurA as chaperone 
(Chimalakonda et al., 2011; Lazar et al., 1998). However, the co-expression of lptD with 
surA and lptE continued to restore the mucoid phenotype of sap27 ruling out misfolding 
of LptD (Figure 2.4). Further expression of optP encoding an OMP of comparable size in 
sap27 did not result in rescuing the mucoid phenotype (Figure 2.4). These results certainly 
argue that LptD, an OMP, may have a specific role in the regulation of alginate production.  
LptD bypasses AlgO107 
It is interesting that the sap27 strain did not have any mutations in the lptD locus 
but in algO. A role for LptD in alginate production is further augmented by its ability to 
rescue the loss of algO in sap22 that was previously identified with the same mutation 
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(Figure 2.4). In a previous publication, the allele was named as algO96 (Sautter et al., 
2012). However, with correction of the ATG start codon location upstream, we renamed 
the allele as algO107. Increasing the expression of lptD bypassed algO107 but failed to 
rescue the alginate phenotype when algO was completely deleted in PDO300. This 
suggests that the presence of truncated AlgO contributes to the observed phenotype. This 
phenotype is independent of the proteolytic activity of AlgO as the truncated protein 
(AlgO107) is missing that catalytic triad Ser490, Asp501, and Lys515. It is not possible to 
rule out that the last 213-amino acid in the AlgO107 is contributing to the observed 
phenotype without further experimentation. Previously, it was argued that MucA22 is the 
substrate for AlgO, a putative serine protease (Reiling et al., 2005).  However, no concrete 
evidence has surfaced to support this argument.  
LptD influences members of RIP cascade 
To determine if LptD played a role in the RIP cascade, algW was deleted in 
PDO300 and PAO1.  The loss of alginate production in PDO∆algW was rescued by 
increasing lptD expression (Figure 2.4). This observation suggests that the release of 
AlgT/U by MucA22 (Figure 1.7 (B)) does not require site-1 cleavage by AlgW, despite the 
fact that the major AlgW cleavage site on MucA (A136 and G137) is still present in MucA22 
(Damron and Yu, 2011). However, in the wild-type P. aeruginosa PAO1, mucoid 
conversion by overexpression of lptD requires AlgW. This finding argues that LptD 
directly or indirectly influences the members of RIP cascade. 
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Two pathways for MucA proteolysis 
As previously shown, our results also suggest a difference in the regulation of 
alginate production in wild-type versus isolates with the mucA22 allele (Qiu et al., 2007). 
In the wild-type background, alginate production is very tightly controlled since MucA is 
intact and protected by MucB against proteolytic cleavage (Cezairliyan and Sauer, 2009). 
We propose that, upon increased expression of lptD, AlgW is activated to initiate MucA  
Figure 2.7. Model for mucoid conversion due to increase expression of lptD in mucA+ 
(PAO1) and mucA22 (PDO300) backgrounds. We proposed that (a) in PAO1, increased 
expression of lptD displaces MucB and induces AlgW to cleave MucA resulting in 
proteolysis of MucA as described previously in figure 1.7. There might not be any role for 
AlgO in PAO1 under the tested conditions. (b) in the mucA22 background, MucB cannot 
bind to MucA, thus the cleavage site of MucA22 is exposed. The overexpression of LptD 
might activate the truncated AlgO leading to MucA22 proteolysis via an unknown 
mechanism. 
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cleavage followed by MucP to release AlgT/U for alginate synthesis (Figure 2.7(a)). In the 
mucoid P. aeruginosa isolates with the mucA22 allele, AlgO seems to be playing an 
important role by activating cleavage of the truncated MucA22 (Figure 2.7(b)) either 
directly or indirectly by means of some unknown protein. Mechanistically, the specific role 
of LptD in the activation of AlgW or AlgO is not clear at the moment. The regulation of 
alginate production due to LptD seems depend on strain backgrounds and requires further 
investigation.  
The X-ray crystal structure of E. coli LptD shows the protein has C-terminal β-
barrel domain while its N-terminal periplasmic domain has a jelly-roll like structure (Dong 
et al., 2014; Qiao et al., 2014). Bioinformatic analysis shows LptD of P. aeruginosa is 
structurally similar to that of E. coli (Werneburg et al., 2012). It is not known whether the 
N-terminal domain of LtpD could interact with other periplasmic proteins to induce 
alginate production. Moreover, it is possible that the N-terminal domain of LptD or LPS 
might displace MucB, leaving MucA vulnerable to proteolysis (Figure 2.7(b)) as seen in 
the E. coli counterpart (Lima et al., 2013; Wilken et al., 2004; Wollmann and Zeth, 2007). 
To understand the mechanistic detail standard protein-protein interaction studies (pull-
down, cross-linking, competition assays) can be performed to explore if there is any direct 
interaction between LptD and MucB and/or MucA. 
Implication 
To date, P. aeruginosa LptD has not been associated with alginate production. P. 
aeruginosa LptD is a target of peptidomimetic antibiotics based on the antimicrobial 
peptide protegrin I that appears to be species-specific (Srinivas et al., 2010; Werneburg et 
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al., 2012). It is also shown that depletion of LptD results in antibiotic susceptibility in P. 
aeruginosa and Acinetobacter baumannii (Balibar and Grabowicz, 2016; Bojkovic et al., 
2015). Furthermore, LptD is a subject of study for a candidate vaccine in Gram-negative 
bacteria such as Neisseria gonorrhea and Vibrio parahaemolyticus (Zha et al., 2016; Zielke 
et al., 2016) Multidimensional protein identification technology showed that in P. 
aeruginosa 63 proteins including LptD are exposed to the extracellular environment 
(Srinivas et al., 2010; Vecchietti et al., 2012). Thus, it would be interesting to determine if 
the peptidomimetic antibiotics, as well as a vaccine against LptD, can prevent alginate 
production in P. aeruginosa. 
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CHAPTER 3 
 
 
 
 
 
Pyridoxal 5’-phosphate (PLP) enhances pyocyanin biosynthesis in Pseudomonas 
aeruginosa 
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Abstract 
Pseudomonas aeruginosa is a metabolically versatile pathogen. In previous chapter 
(Chapter 2), we identified an operon that contains three genes lptD, surA and pdxA. The 
pdxA encoding an outer membrane protein, chaperone protein, and an enzyme involved in 
pyridoxal 5’-phosphate (PLP) biosynthesis, respectively. PLP is also known as vitamin B6.  
PLP biosynthetic pathway has a common precursor, D-erythrose-4-phosphate, that 
converted to chorismic acid that can either synthesize pyocyanin and aromatic amino acids. 
We hypothesized that PLP is involved in P. aeruginosa virulence. Culturing bacteria in 
medium supplemented with PLP resulted in increased pyocyanin production. Among the 
aromatic amino acids, tryptophan, phenylalanine and tyrosine the latter two shunted the 
pathway to produce pyocyanin. The finding in this chapter show that PLP, and aromatic 
amino acids phenylalanine and tyrosine indeed causes P. aeruginosa to increase in 
pyocyanin production suggesting a possible role for pdxA in virulence.  
Introduction 
P. aeruginosa, a Gram-negative bacterium, is a leading cause of infection in cystic 
fibrosis (CF) patients (CFF, 2016). P. aeruginosa is a metabolically versatile organism 
which in part is due to pyridoxal 5’-phosphate (PLP) which is only the active B6 vitamers. 
PLP serves as a cofactor of various essential enzymes that are involved in the metabolism 
of amino acids, fatty acids, and carbohydrates (Percudani and Peracchi, 2003; Percudani 
and Peracchi, 2009). Bioinformatic analyses show 23 proteins encoded by P. aeruginosa 
require PLP as a co-factor (Table 3.1) (Percudani and Peracchi, 2009).  
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 There are two biochemical pathways for PLP biosynthesis, and these pathways are 
mutually exclusive (Fitzpatrick et al., 2007). In P. aeruginosa, the PLP is synthesized by 
a deoxyxylulose-5-phosphate (DXP) dependent pathway (Fitzpatrick et al., 2007). The 
canonical PLP binding sequence is Val-Ile-Tyr-Glu-Thr-Glu-Ser-Thr-His-Lys-Leu-Leu-
Ala-Ala-Phe where either histidine or lysine residue may play a direct role in catalysis  
 
Table 3.1. Predicted ORFs that requires PLP as a co-factor 
S/N Gene Locus Protein 
1 cysM PA0932 Cysteine synthase 
2 
 
PA3659 Probable aminotransferase 
3 bauA PA1232 Beta-alanine-pyruvate transaminase 
4 phnW PA1310 2-aminoethylphosphonate:Pyruvate transferase 
5 phhC PA0870 Aromatic amino acid aminotransferase 
6 pvdH PA2413 Diaminobutyric acid aminotransferase 
7 aruC PA0895 N2-Succinylornithine 5-aminotransferase 
8 aruH PA4976 Arginine:Pyruvate transaminase 
9 selA PA4808 L-seryl-tRNA(Ser) selenium transferase 
10 ldcA PA1818 Probable Orn/Arg/Lys decarboxylase 
11 lysA PA5277 Diaminopimelate decarboxylase 
12 itaA PA5413 Low-specificity L-threonine aldolase 
13 pabC PA2964 4-amino-4-deoxychorismate lyase 
14 trpB PA0036 Tryptophan synthase beta chain 
15 thrC PA3735 Threonine synthase 
16 
 
PA2683 Probable serine/threonine dehydratase 
17 
 
PA3357 D-serine dehydratase 
18 
 
PA0400 probable cystathionine gamma-lyase 
19 alr PA4930 Alanine racemase, biosynthetic 
20 hemL PA3977 Glutamate-1-semialdeyde 2,1-aminomutase 
21 arnB PA3552 UDS-4-deoxy-L-arabinose synthase 
22 cobC PA1276 Cobalamin biosynthetic protein CobC 
23 metZ PA3107 O-succinylhomoserine sulfhydrylase 
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 (Sabo and Fischer, 1974; Wolosker et al., 1999).  The role of the PLP in the production of 
one of the virulence factors, pyocyanin, has not been established yet in P. aeruginosa. 
 
Pyocyanin is a water-soluble, blue-green phenazine compound, and functions as an 
important virulence factor, as it affects P. aeruginosa biofilm development as well as the 
release of extracellular DNA (Baron and Rowe, 1981; Das et al., 2015; Das and Manefield, 
2012; Frank and Demoss, 1959; Grossowicz et al., 1957). In P. aeruginosa, one of the 
precursor molecules of pyocyanin is chorismic acid (Figure 3.1). Chorismic acid is also 
involved in the synthesis of aromatic acid (Palmer et al., 2013; Tamir and Srinivasan, 
1971). The function of pyocyanin is to balance the NADH/NAD+ ratio in the P. aeruginosa 
cytoplasm when the microbes are in stationary phase (Price-Whelan et al., 2007). 
Pyocyanin has been shown to have antibacterial activity against Gram-positive 
bacteria Micrococcus luteus, Gram-negative bacteria E. coli, and Shewanella oneidensis 
(Costa et al., 2015; Kanthakumar et al., 1993; Mazzola et al., 1992). Pyocyanin 
biosynthesis is increased when P. aeruginosa is co-cultured with Candida albicans and 
was shown to be toxic to the fungus (Gibson et al., 2009; Morales et al., 2010; Trejo-
Figure 3.1. Synthesis of pyocyanin from chorismic acid. Chroismic acid undergoes 
biosynthetic reaction to synthesize phenazine-1-carboxylic which is then by enzyme 
PhzM converted to 5-Methylphenazine-1-carboxylic to synthesize pyocyanin by PhzS. 
Courtesy (Rada and Leto, 2013)   
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Hernandez et al., 2014). By using Saccharomyces cerevisiae and the human lung 
carcinoma alveolar type II cell line A549, it was shown that pyocyanin generated reactive 
oxygen species that inactivated human vacuolar ATPase, negatively impacting the lung 
function of people with CF (Ran et al., 2003). Additionally, pyocyanin has been shown to 
cause erythoptosis-inducing effects in erythrocytes suggesting a systemic effect on patients 
suffering from CF (Qadri et al., 2016). In a mouse model, it has been shown that pyocyanin 
caused tissue damage and necrosis that contributed to the development of pneumonia (Lau 
et al., 2004).  
P. aeruginosa harbors two homologous core loci (phzA1-G1 and phzA2-G2) and 
three additional genes (phzM, phzS, and phzH) that are involved in the pyocyanin 
biosynthesis (Figure 3.1)(Mavrodi et al., 2001). None of these genes appear to have a 
canonical PLP-binding site. However, both PLP and pyocyanin synthesis use the same 
starting material, D-erythrose-4-phosphate (Figure 3.2). What drives the reaction toward 
pyocyanin production is unclear. Growing P. aeruginosa in a synthetic CF sputum medium 
supplemented with the aromatic amino acids also enhanced the production of pyocyanin 
(Palmer et al., 2007). It was shown that Pseudomonas quinolone signal (PQS), a cell-cell 
signaling system, positively affects pyocyanin production.  
Recently, we demonstrated that the expression of lptD restores the mucoid 
phenotype in a nonmucoid strain (Pandey et al., 2018). The lptD gene is part of a three-
gene-operon lptD-surA-pdxA. The lptD gene encodes an outer membrane protein (OMP) 
involved in lipopolysaccharide transport (Braun and Silhavy, 2002; Sperandeo et al., 2009; 
Wu et al., 2006). SurA influences the biogenesis of LptD whereas PdxA is involved in 
pyridoxal 5’-phosphate synthesis (PLP) (Figure 3.2)(Denoncin et al., 2010; Vertommen et 
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al., 2009). The PLP is one of the six B6 vitamers that includes pyridoxal, pyridoxine, and 
pyridoxamine and their phosphorylated derivatives PLP, pyridoxine-5-phosphate, and 
pyrdidoxamine-5-phosphate (Figure 3.3). PLP is the only active form of vitamin B6 that is 
serves as cofactor for more than 160 vitamin B6-dependent enzymes (Percudani and 
Peracchi, 2003). The vitamin B6 dependent enzymes are involved in amino acid 
metabolism, amine biosynthesis, carbohydrate breakdown, heme synthesis, nucleic acid 
synthesis and, neurotransmitter biosynthesis (Percudani and Peracchi, 2009). Animals 
cannot synthesize PLP but have to depend on microorganisms and plants (Fitzpatrick et 
al., 2007).  The focus of this chapter is PdxA, as it has not been previously characterized. 
Quorum sensing genes also regulate pyocyanin biosynthesis in P. aeruginosa (Lee and 
Zhang, 2015). Many of these genes are involved in amino acid syntheses. The role of these 
genes in pyocyanin production, however, has never been explored. One of the 
intermediates in the pathway, chorismic acid, can either be funneled into the synthesis of 
aromatic amino acids or pyocyanin (Figure 3.2). 
It is known that the presence of exogenous aromatic amino acids also results in 
pyocyanin production (Palmer et al., 2007). The present study initiated the work needed to 
tease apart the intricate mechanism that drives pyocyanin production and possible 
relationship with PLP. 
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Figure 3.2. Detail pathway for the synthesis of pyocyanin. The pathway to synthesize aromatic amino 
acid, pyocyanin and pyridoxal 5’-phosphate is shown. The solid line and dotted line indicate single and 
multi-step pathways, respectively.  
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Methods 
Bacterial strains, media and growth conditions 
The bacterial strain used in this study is P. aeruginosa PAO1 strain. It was cultured 
overnight at 37 ºC. Then, the next day it was sub-cultured in a flask until an OD600 = 1. 
Then, the culture was diluted to an OD600 = 0.5 in fresh LB. Then, a 2.5-ml of the diluted 
culture was taken and supplemented with aromatic amino acids or PLP to the desired 
concentration to a final volume of 5-ml and the mixture was cultured was incubated for 15 
hours.  
Pyocyanin assay 
 The pyocyanin assay was carried out by extracting the pigment from culture 
supernatant using the chloroform-HCL technique as previously described (Essar et al., 
1990).  
Figure 3.3. Different forms of B6 vitamers. B6 vitamers are pyridoxine, pyridoxamine, 
pyridoxal and their phosphate forms. Pyridoxal 5’-phosphate is active B6 vitamers. 
Courtesy (Vrolijk et al., 2017). 
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A 5-ml culture was centrifuged at 8500 rpm for 10 min at 18 ºC, then 4-ml of the 
supernatant was mixed with 3-ml of chloroform, then the mixture was vortexed for 2 
minutes and the phases were allowed to separate settled down for 20 min. Then, a 2-ml of 
the lower phase was aspirated and mixed with 1-ml of 0.2 N HCl, followed by vortexing 
for 2 min and let it stand for 20 min. Then, the top layer was used to quantify the pyocyanin 
by measuring at the absorbance at 520 nm (A520).  
RNA isolation, cDNA synthesis, and qPCR 
 
All primers used in the experiments were synthesized and supplied by Integrated 
DNA Technologies (Coralville, IA) (Table 3.2).  
Table 3.2. Primers used for qPCR 
S/N Primer name Primers 
1 SP_qRT_phzC1 (F) GGCCGGTGATCCGCGTCG 
2 SP_qRT_phzC1(R) CCGCCGCATAGCCCTTGAG 
3 SP_qRT_phzE1(F) ATGACCTGCTGGCGCTGAT 
4 SP_qRT_phzE1(R) GCGACCGATCTCGTCGGCG 
5 DBS_qRT_clpX(F) TGCGATTACGATGTGGAGA 
6 DBS_qRT_clpX(R) CCCTCGATGAGCTTCAGCA 
 
The Ribonucleic acid (RNA) was isolated from the prototypic P. aeruginosa grown 
in LB broth. Briefly, the overnight culture of P. aeruginosa grown in LB broth at 37 °C 
was washed with sterile 0.85 % saline solution to remove spent media and was sub-cultured 
at 37 °C, 200 rpm in LB media. When the cells reached an optical density of 600 nm 
(OD600) of 0.6 - 0.7 the bacterial culture was treated with 5.92 mM PLP for 1 hour. Post-
treatment, RNA was stabilized by addition of phenol-ethanol mixture. The stabilized RNA 
was then isolated using RNeasy Mini Kit (Qiagen, Inc Venio, Limburg, Netherland) as per 
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the manufacturer’s protocol. Residual genomic DNA contamination was removed using 
RQ1 RNase-free DNase (Promega, Madison, Wl, USA) and RNA was re-purified using 
Rneasy kit (Qiagen, Inc Venio, Limburg, Netherlands). The quality of purified RNA was 
assessed on a denaturing agarose gel (NorthernMax Gly, Ambion, Life Technologies, 
Carlsbad, CA, USA) and quantified at 260 nm (BioTEK, Synergy HT, Winooski, VT, 
USA). The complementary DNA (cDNA) was then synthesized by annealing NS5 random 
primers to total purified RNA and subsequent extension was carried out using SuperScript 
lll reverse transcriptase (Invitrogen, Life Technologies, Carlsbad, CA, USA). The 
quantitative polymerase chain reaction (qPCR) to study expression levels of phzC1 and 
phzE1 under PLP induction was performed using an Applied Biosystem Step One cycler 
and detection system with PowerSYBR Green PCR MasterMix with ROX (Applied 
Biosystems, Life Technologies, Carlsbad, CA, USA). The cycling conditions used were 95 
°C (2 minutes, holding); 40 cycles of 95 °C (15 sec), 60 °C (60 seconds, cycling); 95 °C 
(15 second), 60 °C (1 minute), 95 °C (15 second) (0.6 °C ramp) (melt curve). Expression 
was normalized to the housekeeping gene clpX (PA1802), whose expression remained 
unchanged under the tested conditions.  
Results 
PLP up-regulates the pyocyanin production 
To investigate the role of PLP in pyocyanin biosynthesis, P. aeruginosa was 
cultured for 15 hours in LB with and without PLP. The assay showed that P. aeruginosa 
produced a significantly higher quantity of pyocyanin in the presence of PLP suggesting 
that PLP influences a role in pyocyanin biosynthesis P. aeruginosa (Figure. 3.4). 
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Pyocyanin production in the presence of aromatic amino acids 
 Common precursor molecules, chorismite and anthranilate are used to synthesize 
pyocyanin, pseudomonas quinolone signal, and aromatic amino acids (Figure 3.3) (Lee and 
Zhang, 2015). So, we hypothesized that supplementation of aromatic amino acids in LB 
medium would divert intracellular chorismate to pyocyanin synthesis. To test this 
hypothesis, P. aeruginosa was grown in LB medium supplemented with different 
concentrations of phenylalanine, tyrosine, and tryptophan. There was no significant change 
in pyocyanin production when P. aeruginosa was grown in the LB medium supplemented 
with tryptophan (Figure 3.4). Pyocyanin was significantly overproduced when P. 
aeruginosa was grown in LB supplemented with phenylalanine and tyrosine (Figure 3.4).  
Pyocyanin biosynthesis 
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Figure 3.4. Pyocyanin production in the presence of PLP and aromatic amino acids. 
P. aeruginosa PAO1 was grown in aromatic amino acids or PLP and levels of pyocyanin 
were quantified. 
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PLP increases the transcription of the pyocyanin biosynthesis operon  
In P. aeruginosa, two operons are involved in pyocyanin biosynthesis. The 
pyocyanin biosynthesis operon phz1 (phzA1B1C1D1E1G1) is located at positions 
4,713,795 to 4,720,062 bp in the genome, while the other operon, phz2 
(phzA2B2C2D2E2G2), is located approximately 2.6 Mb from phz1 at the position 
2,070,685 to 2,076,985 bp (Winsor et al., 2016). One operon is required for pyocyanin 
biosynthesis (Cui et al., 2016; Recinos et al., 2012).  
 
To identify whether PLP affects phenazine genes at the operons at the 
transcriptional level, we determined the relative levels of phzC1 (PA4212) and phzE1 
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Figure 3.5. Expression of genes in phz-operon due to PLP. P. aruginosa PAO1 was 
grown in LB media supplemented with or without vitamin B6. Then RNA was isolated, 
and cDNA was synthesized. The qPCR was done to quantify the expression level phzC1 
and phzE1. 
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(PA4214) transcripts by qPCR. P. aeruginosa PAO1 was grown in LB media 
supplemented with/without PLP. Complementary DNA (cDNA) was synthesized and 
qPCR was performed using the primers shown in (Table 3.2). Our result showed that phzC1 
and phzE1 transcripts increased three and five-fold, respectively, when P. aeruginosa was 
grown in the PLP-treated versus untreated media (Figure 3.5). Our results indicate that PLP 
increases the transcription of the phz1 operon. However, whether PLP directly or indirectly 
plays a role in the increased transcription of phz1 operon remain to be explored. 
Discussion 
Little is known about the role of PLP biosynthesis and its role in the virulence of 
bacteria. Neither the biosynthesis pathway in P. aeruginosa nor the importance of PLP in 
virulence has been explored. In this chapter, the role of PLP, as well as preliminary 
mechanism of pyocyanin biosynthesis when the P. aeruginosa is grown in medium 
supplemented with PLP, is explored.   
PLP is synthesized in bacteria via two de novo pathways known as deoxyxylulose-
5-phosphate (DXP)-dependent and DXP-independent pathway (Fitzpatrick et al., 2007). 
The DXP-dependent pathway has been mostly present in  proteobacteria such as P. 
aeruginosa where pdxA is involved in synthesis of 2-amino-3-oxo-4-phosphoxoybutanoate 
from 4-phospho-hydroxy-L-threonine (Figure 3.2). Our results showed that the growth of 
P. aeruginosa in the presence of PLP increased the production of pyocyanin production, 
one of the virulence factors of P. aeruginosa.  The pyocyanin and PLP are synthesized 
from a common precursor D-erythrose -4-phosphate (Figure 3.2). From D-erythrose-4-
phosphate either PLP or chorismic acid is synthesized via two independent biosynthetic 
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pathways. The chorismic acid further can be used to synthesize either aromatic amino acids 
or pyocyanin (Figure 3.2).   We hypothesized that culturing of P. aeruginosa in presence 
of PLP shunted D-erythrose-4-phosphate to a pathway in favor of pyocyanin production. 
Furthermore, since chorismic acid is used synthesis of either aromatic amino acid or 
pyocyanin production, we hypothesized that in excess of aromatic amino acids, chorismic 
acid would push the pathway to the production of pyocyanin. Our results suggest indeed 
growth of P. aeruginosa in a media supplemented with aromatic amino acids tyrosine and 
phenylalanine increased the production of pyocyanin.  
Our data show that among the three aromatic amino acids the highest amount of 
pyocyanin was produced when P. aeruginosa was cultured in LB medium supplemented 
with excess phenylalanine whereas lowest in the presence of tryptophan. The higher 
amount of pyocyanin biosynthesis when P. aeruginosa was grown in presence of 
phenylalanine may be the result of the existence of the aromatic amino acid permease 
transport systems I and II (Kay and Gronlund, 1971). The aromatic amino acid permease 
transport system transport systems have different affinities for the three aromatic amino 
acids, system I recognizes and transports phenylalanine, tyrosine, and tryptophan 
respectively in this order, whereas the aromatic transport system II recognizes tryptophan, 
phenylalanine, and tyrosine in this order (Kay and Gronlund, 1971). In addition, it has been 
shown that phenylalanine and tyrosine accumulates inside P. aeruginosa to a concentration 
approximately 10 times greater than that found for tryptophan (Kay and Gronlund, 1971).  
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Future direction 
The results still leave the role of pdxA unanswered. The only way to show pdxA 
role in virulence and vitamin B6 synthesis is by constructing knockout strain. However, 
attempts to delete the gene failed suggesting that it is an essential gene, as such a 
conditional mutant need to be constructed.    
Construction of a conditional pdxA mutant  
A strain with the pdxA gene under the control of the araBAD promoter (PBAD) 
should be constructed. A 300-bp spanning the 5’ region of pdxA was PCR amplified from 
the genome of PAO1 using the primers SP_pdxA300_ EcoRI_(F) and SP_pdxA300_ 
Figure 3.6. Strategy to construct pdxA conditional mutant of P. aeruginosa. The 
methods of construction of pdxA conditional mutation PAO1. 
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HindIII_(R). The PCR product was digested with EcoRI and HindIII and ligated 
downstream of PBAD promoter into pMQ72 digested with EcoRI and HindIII and the 
plasmid was called as pMQ72-pdxA300. Resulting plasmid pMQ72-pdxA300 was used to 
amplify a 2,239-bp fragment containing araC-pdxA300-T1T2 using the primer pairs pBAD 
(F) and pBAD (R). The fragment was then digested with XhoI and XbaI and ligated into 
integration proficient vector pEXG2 digested by the same restriction enzymes resulting in 
the plasmid pEXG2PBAD:pdxA300. The plasmid pEXG2PBAD:pdxA300 was used to transform 
E. coli. The plasmid was then transferred into P. aeruginosa PAO1 by triparental mating, 
with the selection of the conditional mutant on PIA (Difco) medium supplemented with 
arabinose (0.5%) and Gm (100 μg ml-1). The integration was confirmed by sequencing and 
PCR, resulting in the strain PAO1-pEXG2:pdxA300 (Figure 3.6). 
qPCR analysis of the first genes in the pathways, namely gapA, phzC, and phzE   
We postulate that the presence of PLP will result in the decreased expression of 
gapA and increased expression phzC and phzE (Figure 3.3). Briefly, wild type and pdxA 
mutant strain should be grown in M9 broth at 37 °C in the presence of arabinose and glucose 
(to deplete PdxA) for 3 hours, and RNA should be isolated using RNeasy Mini Kit (Qiagen) 
as per the manufacturer’s protocol. The RNA should be purified, and cDNA should be 
synthesized. The qPCR of the respective genes (Figure 3.2) should be performed to explore 
the possible pathway for pyocyanin production when P. aeruginosa is grown in the 
presence of PLP. 
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CHAPTER 4 
 
 
 
 
Discussion 
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Living cells have a sophisticated regulatory mechanism that controls how they 
transduce the environmental clues downstream to the cell. One of the mechanisms that are 
evolutionarily conserved from humans to bacteria is termed regulated intramembrane 
proteolysis (RIP). The RIP process is predominantly involved in a progressive two-step 
proteolytic degradation initiated by the cleavage of a single-span transmembrane protein 
ultimately releasing extracellular and/or intracellular fragments (Brown et al., 2000; 
Lichtenthaler and Steiner, 2007; Qiu et al., 2007). The RIP system in cells functions in 
various ways, including proliferation, differentiation, protein degradation, cell adhesion, 
lipid metabolism, mitophagy, and transcriptional regulation (Damron and Yu, 2011; Qiu et 
al., 2007; Shanbhag et al., 2012; Yoshida et al., 2013). In this dissertation, we explored the 
activation of the RIP system of P. aeruginosa by an outer membrane protein referred as 
lipopolysaccharide transport protein D (LptD). The lptD is part of three gene operon lptD-
surA-pdxA. The PdxA is involved in synthesis of pyridoxal 5’-phosphate (PLP). Culturing 
P. aeruginosa in the LB supplemented with the of PLP shows the increase in biosynthesis 
of pyocyanin. The pyocyanin and aromatic amino acid are synthesized from chorismic 
acid. Culturing P. aeruginosa in LB media supplemented with aromatic amino acids; 
phenylalanine and tyrosine also increase the pyocyanin production.  
A variety of organisms, including bacteria, fungi, parasites, viruses and other agents 
are the cause of nosocomial infections. Recently, using data from hospital-based 
surveillance studies and Infectious Diseases Society of America, a certain group of 
nosocomial pathogens has been referred to as ESKAPE pathogens (Peters et al., 2008; 
Pogue et al., 2015; Rice, 2010). The ESKAPE pathogens includes a group of both Gram-
negative and Gram-positive bacteria made up of   Enterococcus faecium, Staphylococcus 
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aureus, Klebsiella pneumoniae, Acinetobacter baumannii, P. aeruginosa, and 
Enterobacter species. Among ESKAPE pathogens, P. aeruginosa is a formidable pathogen 
because of its metabolic versatility, intrinsic and acquired antibiotic resistance, biofilm 
formation, and production of multiple virulence factors. One of the virulence factors of P. 
aeruginosa is the exopolysaccharide alginate (Hoiby, 1975). Alginate production in the 
lung of the CF patients infected by P. aeruginosa indicates a chronic infection that leads 
to a poor prognosis (Hoiby et al., 1977; Pedersen et al., 1992).  Thus, it is important to 
understand the genes involved and their mechanism of action in the production of alginate 
in P. aeruginosa. One part of this study focused on identifying novel genes associated with 
the production of alginate and pathways of alginate production while in the other section, 
we investigated the production of another virulence factor pyocyanin. 
CF individuals are thought to be initially colonized by P. aeruginosa from diverse 
environmental sources as well as from CF clinics (Denton et al., 2002; Jensen et al., 1997; 
Romling et al., 1994; Scott and Pitt, 2004).  Initial colonizing P. aeruginosa strains have 
non-mucoid phenotype with a wild-type mucA, however, mucoid mucA mutants eventually 
emerge and dominate the population of P. aeruginosa in the CF lung (Martin et al., 1993). 
In wild-type PAO1 MucA sequesters AlgT/U at the inner membrane, preventing the sigma 
factor from directing RNA polymerase to transcribe the alginate transcriptome; however, 
when mucA is mutated, AlgT/U is free to guide RNA polymerase (Schurr et al., 1996). In 
the clinical setting, it has been found that 25% of mucoid P. aeruginosa isolated from CF 
individuals has a deletion of a single guanine nucleotide (G) in a string of five G nucleotides 
located at 426-430 bp in mucA ORF (Martin et al., 1993; Schurr et al., 1996). In this study, 
we used a constitutively mucoid laboratory strain PDO300 (PAOmucA22) that was derived 
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from non-mucoid PAO1 (Mathee et al., 1999). The mucoid PDO300 was grown under 
oxygen-limited conditions, a stressful situation that reverts the metabolically demanding 
mucoid PDO300 to non-mucoid phenotype which are referred to as the suppressor of 
alginate production (sap) mutants (Mathee et al., 1999). One of the sap mutants that is of 
interest in this dissertation is sap27. To identify mutations in sap27 mutants, the strains 
were complemented with the PAO1 minimum tiling path (MTP) library that was previously 
divided into four pools (Sautter et al., 2012). The four pools of cosmids were introduced 
into the sap27 and mucoid phenotype of the strains was screened. The junctional 
sequencing revealed that cosmid pMO012217 restored the mucoidy of the sap27. Finally, 
by transposon mutagenizing the cosmid pMO012217 that restored the mucoid phenotype, 
we mapped lptD (PA0595) that can restore the mucoid phenotype of one of sap27 and lptD-
surA-pdxA forms an operon (chapter 2). The pdxA is involved in pyridoxal 5’-phosphate 
(PLP) synthesis in Gram-negative bacteria. Culturing P. aeruginosa in LB media 
supplemented with PLP as well as aromatic amino acids phenylalanine and tyrosine 
increases the production of pyocyanin (chapter 3). The pyocyanin is one of the virulent 
factors of P. aeruginosa (Gibson et al., 2009; Kanthakumar et al., 1993; Morales et al., 
2010).  
Outer membrane protein LptD 
Previously, LptD was known as Imp and OstA (Abe et al., 2003; Aono et al., 1994; 
Sampson et al., 1989). The protein has been extensively studied and deemed as a promising 
vaccine antigen and potential immunotherapeutic target in several Gram-negative bacteria, 
such as Neisseria gonorrhoeae, A. baumannii, Neisseria meningitidis, Vibrio 
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parahaemolyticus and P. aeruginosa (Balibar and Grabowicz, 2016; Bojkovic et al., 2015; 
Bos et al., 2004; Zha et al., 2016). The role of LptD, along with other seven essential 
proteins (LptA-LptG), is to transport lipopolysaccharide (LPS) to the cell surface, thus 
involved in outer membrane biogenesis (Braun and Silhavy, 2002). LptD is an outer 
membrane protein (OMP) with a C-terminal -barrel and an N-terminal jellyroll domain 
containing three nonconsecutive disulfide bonds (Srinivas et al., 2010; Werneburg et al., 
2012). Survival protein during stationary phase (SurA), 17-Kilodalton Protein (Skp), and 
FK506-binding protein A (FkpA) maintain the folding-competent state while LptD is 
translocating from the periplasm to the outer membrane (Bitto and McKay, 2002; Rouviere 
and Gross, 1996; Schwalm et al., 2013; Tormo et al., 1990). In the outer membrane, the 
Bam complex assembles LptD in coordination with LptE (Lee et al., 2016). The three 
disulfide bonds are rearranged to become a mature LptD-LptE complex (Moehle et al., 
2016). 
LPS is the major endotoxin that stimulates the host inflammatory response (Janda, 
1972; Raetz and Whitfield, 2002; Rosenfeld et al., 2006). In mice, LptD induces a strong 
host immune response (Zha et al., 2016). LptD is an essential outer membrane protein of 
most of the Gram-negative bacteria and has the capacity to generate an immune response 
in humans, making the protein an ideal universal vaccine candidate (Srinivas et al., 2010; 
Zha et al., 2016). Photoaffinity labeling, liquid chromatography-electrospray ionization 
tandem mass spectrometry (LC-ESI-MS-MS) and a polyclonal antibody raised against a 
C-terminus domain of LptD show that the LptD is an outer membrane protein with a mass 
of approximately 100 kDa (Srinivas et al., 2010). We also confirmed the finding that LptD 
localizes to the membrane fraction of P. aeruginosa (Figure 2.5). 
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The role of the second gene of the lptD-operon, surA, in LptD translocation  
In all organisms, proteins are translated primarily by the cytosolic ribosome and 
such proteins have to be transported to various cellular locations. In bacterial cells, three 
known translocation processes that transport the proteins across the cell membrane have 
been  reported: (a) Sec-mediated translocation across the cytoplasmic membrane (Manting 
and Driessen, 2000); (b) twin-arginine transport-mediated translocation across the 
cytoplasmic membrane (Palmer and Berks, 2012); and (c) more specialized mechanisms 
for delivery of specific proteins to the outermost surface of the cell (Thanassi and Hultgren, 
2000). Of these mechanisms, one of the major pathways of protein translocation from the 
cytosol across the inner membrane in bacteria is provided by the Sec machinery (Corey et 
al., 2016; Duong and Wickner, 1997; Nouwen and Driessen, 2002). Transportation of outer 
membrane proteins initiates with the translocation of nascent OMPs through the Sec 
machinery located in the inner membrane (Huber et al., 2017). Once in the periplasm, 
nascent OMPs interact with periplasmic chaperones such as SurA (Hennecke et al., 2005; 
Xu et al., 2007). SurA has been shown to interact directly with the A2 helix of β-barrel 
assembly machinery A (BamA) polypeptide transport-associated protein (POTRA 1) 
(Bennion et al., 2010). No data exists that shows the interactions with other periplasmic 
chaperones, including the 17- kilodalton protein (Skp) and degradation protein P (DegP). 
Chaperone-bound OMPs are then thought to be offloaded to the BamA POTRA domain by 
a mechanism known as β-augmentation, in which the β-strands of substrate OMPs align 
with the β-strand of POTRA in a sequence and orientation-independent manner (Workman 
et al., 2012). It has been shown in surA mutant of an E. coli that the transcription of lptD 
is not significantly affected but the LptD protein levels are decreased suggesting that in the 
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periplasm SurA is the true chaperon of LptD (Vertommen et al., 2009). The LptD is a true 
substrate of SurA is further reinforced by the fact that in γ-proteobacteria, the lptD-surA 
operon is conserved even though nearby genes are not (Braun and Silhavy, 2002; Winsor 
et al., 2016). This further suggests that the LptD is a preferred substrate of SurA. 
Furthermore, it has been shown that though LptD is highly dependent on SurA as its 
preferential chaperone protein, other periplasmic chaperone proteins such as Skp and FkpA 
are also required for the assembly of LptD (Schwalm et al., 2013).  
In E. coli, the domains of SurA consists of the N-terminal domain [aa 21 -162], P1 
domains [aa 172-274], P2 domain [aa 282-385], and C-terminal domain [aa 388-428](Bitto 
and McKay, 2002). The N and C-terminals of SurA including P2 act as the core chaperone 
module whereas the P1 domain is known as an inactive peptidyl-prolyl-cis/trans isomerase 
(PPIase) domain. The P1 form makes noncovalent interactions with the core chaperone 
module that occludes the function of SurA. Both P1 and P2 domains are dispensable as 
mutants lacking these domains are sufficient for the chaperone function of SurA in vitro. 
SurA has been shown to bind to peptides that are rich in aromatic amino acids (Hennecke 
et al., 2005). 
Role of LptE in the proper folding of LptD in the outer membrane 
In E. coli, His-tagged LptD was used initially to show that LptE and LptD interact 
and later it was found that the proteins interact in 1:1 ratio (Chng et al., 2010; Wu et al., 
2006). Through pull-down experiments, it was shown that the both the full length LptD as 
well as only C-termini LptD tagged with histidine (C-LptDHis) could pull down similar 
amounts of LptE, suggesting that the LptE interacts with the C-terminus of LptD (Chng et 
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al., 2010). In E. coli, LptE helps in the proper rearrangement of disulfide bonds present in 
LptD but the exact mechanism is not known (Ruiz et al., 2010). LptD of P. aeruginosa is 
composed of 924 amino acids. The periplasmic domain of the LptD (34- 323) is 100 amino 
acids longer than LptD of E. coli and contains a pair of cysteine residues that could form a 
disulfide bond. In SDS-PAGE, heat denatured LptD with and without reduction with 
dithiothreitol (DTT) showed denatured and non-reduced LptD with an apparent size of 130 
kDa and the DTT-reduced form with  an apparent size of 100 kDa suggesting the presence 
of a putative interdomain di-sulfide bond (Andolina et al., 2018). Additionally, by 
sequential replacement of all six cysteine residues to serine and examining the gel mobility 
of such modified LptD in SDS-PAGE showed that the protein is of 100 kDa, suggesting 
the presence of internal disulfide bonds of LptD (Andolina et al., 2018). The Ni-affinity 
pull down showed LptD was co-purified along with LptEHis, indicating both proteins 
interact with each other but how LptE helps in the rearrangement of disulfide bond present 
in LptD remains to be explored (Andolina et al., 2018).   
Alginate production 
In the lungs of patients with cystic fibrosis, P. aeruginosa starts with a non-mucoid 
phenotype and converts to an alginate overproducing mucoid phenotype, indicating of a 
chronic infection (Evans and Linker, 1973; Govan and Fyfe, 1978; Pressler et al., 2011a). 
It has been shown that motile P. aeruginosa eventually deposited into the hypoxic mucus 
zone in the lung of CF airway responds to such oxygen-limiting conditions by increasing 
alginate production (Worlitzsch et al., 2002). Alginate is a linear polymer of -D-
mannuronic acid and the -L-guluronic acid that has an ability to stimulate the production 
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of antibodies IgA and IgG (Aanaes et al., 2013; Evans and Linker, 1973; Pedersen et al., 
1990). 
Alginate production in P. aeruginosa involves a very complex regulatory process 
where the key player is an alternative sigma factor AlgT/U (Devries and Ohman, 1994a; 
Martin et al., 1993a). The activity of AlgT/U is post-translationally inhibited by the anti-
sigma factors MucA and MucB (Goldberg et al., 1993; Martin et al., 1993b; Martin et al., 
1993; Mathee et al., 1997). The release of AlgT/U from MucA is regulated by a mechanism 
known as the regulated intramembrane proteolytic pathway (RIP)(Qiu et al., 2007). In the 
RIP pathway, MucA undergoes sequential degradation and such degradation process is 
stimulated by the action of the periplasmic/outer membrane protein MucE due to the 
accumulation of unfolded proteins in the periplasm or the stress in the outer membrane 
activates MucE (Qiu et al., 2007). The activated-MucE interacts with AlgO to activate the 
inner membrane proteolytic protein AlgW to cleave MucA (Cezairliyan and Sauer, 2009; 
Qiu et al., 2007). The AlgW-cleaved MucA undergoes further cleavage by MucP, 
eventually releasing AlgT/U with a small portion of MucA still bound to it (Damron and 
Yu, 2011; Qiu et al., 2007). A cytoplasmic protein, SspA, guides the complex of cleaved 
MucA-AlgT/U to ClpXP where the remaining portion of MucA is degraded and eventually 
AlgT/U is free to bind to RNA polymerase (Qiu et al., 2008b; Yin et al., 2013). The AlgT/U 
bound RNA polymerase directs the transcription of its own algT/U-operon and other 
transcription factors AlgR, AlgB, and AmrZ (Devries and Ohman, 1994a; Martin et al., 
1994; Wozniak and Ohman, 1994; Wozniak et al., 2003). These transcription factors AlgR, 
AlgB, and AmrZ along with RNA polymerase-AlgT/U complex direct the transcription of 
algD promoter for the biosynthesis of alginate (Baynham and Wozniak, 1996; Kato and 
 
101 
Chakrabarty, 1991; Leech et al., 2008; Mohr et al., 1991; Mohr et al., 1992).  AlgR not 
only regulates the algD-operon but also activates the transcription of algC that encodes a 
phosphomannomutase or phosphoglucomutase, which is essential for alginate, Psl, and 
rhamnolipid production (Lizewski et al., 2004; Wozniak and Ohman, 1994; Zielinski et 
al., 1991). Another important regulator of alginate production in P. aeruginosa is 
diguanylate cyclase/phosphatase, which by regulating the local pool of bis- (3’-5’)-cyclic 
dimeric GMP (c-di-GMP) in the vicinity of the pili Z (PilZ) domain of the inner membrane 
protein Alg44, positively influencing the alginate production in P. aeruginosa (Hay et al., 
2009; Merighi et al., 2007; Remminghorst and Rehm, 2006). 
Role of LptD the alginate production: a potential model  
Our results show that an outer membrane protein, LptD, acts as a positive regulator 
of alginate production (Chapter 2)(Pandey et al., 2018). We showed that in a mucA mutant 
background, LptD is capable of restoring the mucoid phenotype. To understand the 
hierarchy of LptD in the RIP cascade, algW was deleted in both PAO1 and PDO300. LptD 
rescued the mucoid phenotype in PDOalgW suggesting that in a mucA mutant 
background, LptD acts upstream of AlgW in the RIP cascade whereas, in the case of 
PDOalgO, LptD failed to restore the mucoid phenotype. But, increasing the production 
of LptD in sap27 restores the mucoid phenotype suggesting LptD might interact with AlgO 
to produce the mucoid phenotype in a mucA mutant background. However, in wild type 
PAO1, increased expression of LptD, AlgO is dispensable for rescuing mucoid phenotype. 
Based on this evidence, we concluded that LptD dependent alginate production is strain 
specific (Figure 2.8). 
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Role of PLP in pyocyanin production in P. aeruginosa 
 
The lptD gene is part of a three-gene-operon lptD-surA-pdxA. The lptD gene 
encodes an outer membrane protein (OMP) involved in lipopolysaccharide transport. 
Additionally, it has been shown that lptD positively influences alginate production (Pandey 
et al., 2018). SurA is the cognate chaperone protein of LptD, and PdxA plays an important 
role in vitamin B6 synthesis (Figure 3.2) (Denoncin et al., 2010; Fitzpatrick et al., 2007; 
Laber et al., 1999; Rouviere and Gross, 1996). One of the aims of this dissertation was also 
to explore the role of vitamin B6 in the virulence of P. aeruginosa. 
In E. coli, PdxA acts as an enzyme for the synthesis of vitamin B6 (Laber et al., 
1999). The importance of vitamin B6 for bacterial pathogenesis has been demonstrated in 
Mycobacterium tuberculosis, Bacillus subtilis, Campylobacter jejuni, and Helicobacter 
pylori (Asakura et al., 2013; Dick et al., 2010; Grubman et al., 2010; Raschle et al., 2005). 
Our data suggest that vitamin B6, and the aromatic amino acids tyrosine and phenylalanine 
play a role in increased pyocyanin production in P. aeruginosa (Figure 3.3). But, the roles 
of PLP, tyrosine, and phenylalanine in pyocyanin production in P. aeruginosa remain 
unknown. 
Future directions 
This is the first report of an OMP component that plays a role in regulating alginate 
production. This study also opened many unanswered questions. Delineating the role of 
the LptD in the RIP cascade can help in identifying stress signals that trigger upstream or 
downstream proteolysis of MucA that releases the AlgT/U for mucoid conversion of P. 
aeruginosa. By targeting LptD as a drug target, a tool can be developed to prevent alginate 
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production. Secondly, MucD, AlgO, AlgW, and MucP are protease proteins. To achieve 
better treatment outcomes in chronic P. aeruginosa infections identifying the inhibitors of 
the proteases that can prevent alginate production can be a significant strategy. Finally, it 
is well established that microbes and plants can only synthesize pyridoxal 5’-phosphate 
(PLP) and humans have to depend on them for metabolic needs. By targeting the P. 
aeruginosa PLP biosynthesis pathway, growth or virulence factors of pathogenic microbes 
can be specifically inhibited that could result in the better prognosis for CF patients and 
prevent other infections by the microbe.  
Identify the role of LptD/OstA in alginate regulatory cascade 
To determine the role and point at which LptD/OstA is involved in 
the alginate regulatory cascade, mucD, mucE, algW, algO and mucP can be 
expressed in the lptD mutant strain. Next, lptD/ostA can be expressed in 
mucD, algW, algO and mucP deletion strains. Then, the presence and 
absence of a mucoid phenotype can be scored. Based on the results, the 
location and role of the LptD/OstA in the alginate pathway can be deduced. 
Identify proteins interacting with LptD/OstA 
LptD might interact with a periplasmic protein to exert its effect on 
alginate production. To date, known periplasmic proteins associated with 
alginate production are MucD, MucE, AlgO, and MucB. To determine the 
mechanism of action of LptD for alginate synthesis, it is imperative to 
identify the protein/s that interact with LptD. A co-immunoprecipitation 
assay can be done with His-tagged LptD to find its interacting partners. 
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Conversely, the periplasmic proteins (MucB, AlgO, MucD, and MucE) can 
be His-tagged for the pull-down assay. The interacting partners can be 
identified using antibodies against the known proteins. In E. coli, SurA acts 
as a chaperone for LptD and LptE binds in the lumen of LptD 
(Chimalakonda et al., 2011; Chng et al., 2010; Denoncin et al., 2010; 
Moehle et al., 2016). This suggests that LptD might interact with other non-
alginate periplasmic proteins. To test LptD-SurA or LptD-LptE interaction 
in P. aeruginosa, His-tagged SurA or LptE can be used in co-
immunoprecipitation assays.  
LptD as a drug target 
LptD and the lipoprotein LptE are essential for the transport of 
lipopolysaccharide molecules from the periplasm to the outer leaflet of the 
outer membrane for the outer membrane biogenesis of in Gram-negative 
bacteria (Chng et al., 2010). It has been shown that macrocyclic 
peptidomimetics and the related molecule Murepavadin specifically target 
LptD inhibiting the LPS translocation in Pseudomonas spp. (Andolina et 
al., 2018; Srinivas et al., 2010; Werneburg et al., 2012). Our result showed 
LptD in P. aeruginosa is also involved in alginate production (Chapter 2). 
Thus, it is possible that the peptidomimetic drugs could also inhibit alginate 
production by P. aeruginosa, which has not been explored yet. 
Role of truncated AlgO in sap27 
LptD restored the mucoid phenotype of sap27 (Figure 2.3b) but 
could not restore the phenotype of PDOalgO. Both of the strains have 
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mucA22 allele but truncated AlgO is present in the sap27 whereas, in the 
PDOalgO, the gene is deleted. This led to the hypothesis that the truncated 
AlgO could still retain the function in sap27. It would be interesting to test 
whether the truncated AlgO has retained all or part of its function. 
Identification of small molecule inhibitors of alginate production 
The chronic infection in CF patients is the appearance of an increase 
in alginate production causing a mucoid phenotype in P. aeruginosa. The 
mucoid phenotype of the bacterium makes antibiotic treatments ineffective. 
The trypsin-like serine proteases (MucD and AlgW), a serine protease 
(AlgO) and Zn-dependent protease (MucP) play a central role in the alginate 
production pathway in P. aeruginosa. Identification of specific proteinase 
inhibitors of MucD, AlgW, AlgO, and MucP could be useful therapeutic 
agents to prevent alginate production. Commercial proteinase inhibitors 
from G-biosciences or Sigma that can act on either of MucD, AlgW, AlgO, 
and MucP. The available literature showed that between two inner 
membrane proteases AlgW and MucP, the MucP is the essential protease 
for the proteolytic cleavage of both MucA or its mutant allele MucA22. 
MucP is Zn metalloproteinase. Thus, it may be worthwhile to use screening 
of Zn metalloproteinase inhibitors to impede alginate production by P. 
aeruginosa. Fortunately, a database for wide range of metalloproteinase 
inhibitors are available (Muvva et al., 2016). Culturing mucoid P. 
aeruginosa in the presence of the protease inhibitors and screening for the 
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loss of mucoidy could be a strategy to identify potential inhibitors of 
specific protease proteins. Finally, the mechanism of action of the protease 
inhibitors can be explored. 
Identification of small molecule inhibitors of pyocyanin production 
Culturing P. aeruginosa in a media supplemented with PLP 
increased pyocyanin production. Pyocyanin is one of the virulence factors 
of P. aeruginosa. By identifying the proteins affecting pyocyanin 
production due to PLP, screening for small molecule inhibitors of the 
proteins can be done that could ultimately make P. aeruginosa less virulent. 
It is also important to note that PLP acts as a co-factor for 23 P. aeruginosa 
proteins. Thus, by inhibiting the activity of PLP synthesis, we can affect the 
metabolic activity of the microbe such that its growth and/or its virulence 
can be inhibited. 
Mechanism of cleavage MucA in the membrane 
Generally, the membrane-spanning segment of a protein forms  
helices. Hydrogen bonds preclude the proteolytic cleavage of peptide bonds 
present in the  helices (Paetzel et al., 1998). How AlgW and MucP can get 
access to the peptide bond of MucA for the cleavage is still unresolved. It 
might be possible that due to the release of MucB, the MucA might undergo 
a conformational change or it could form a  strand-like conformation that 
becomes more susceptible to proteolysis as previously predicted (Hubbard 
et al., 1994; Matthews, 1988). 
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Final conclusions and implications 
This dissertation identified an outer membrane protein referred to as 
Lipopolysaccharide transport protein D (LptD), as a component of alginate production 
pathway. The LptD is likely to interact with periplasmic protease protein AlgO and inner 
membrane protease protein AlgW for restoration of the alginate production by suppressor 
of alginate production (sap) mutant sap27. The non-mucoid sap27 is derived from PDO300 
that consecutively mucoid phenotype. The sap27 has a mutation in the AlgO.  
The last gene of lptD-surA-pdxA forms an operon. It is well established that pdxA 
is involved in pyridoxal 5’-phosphate synthesis (PLP), an active form of vitamin B6. 
Culturing the P. aeruginosa in excess PLP and aromatic amino acids phenylalanine and 
tyrosine increases pyocyanin production. 
 This investigation led to the finding of an outer membrane protein (OMP) that is 
important in alginate gene regulation in P. aeruginosa and this discovery could increase 
the chance of a potential treatment option. OMPs are an easier target because the effect of 
an efflux pump that might reduce the efficacy of the drug is bypassed. Additionally, data 
in this dissertation show that PLP and aromatic amino acids; phenylalanine and tyrosine 
enhance the production of pyocyanin. Targeting the proteins involved in the biosynthesis 
of PLP and aromatic amino acid could be a potential way to limit the infection caused by 
P. aeruginosa.   
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